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1 Introduction 
1.1 Atopic diseases 
Atopy - derived from the Greek word “atopia”, meaning “unusual” or “out of place” - refers to a 
predisposition towards an aberrant production of IgE as a response to common allergens. The 
prevalence of atopic diseases increased during the last half century (Devereux 2006). Clinical 
manifestations of atopic diseases may include atopic eczema, allergic asthma and/or allergic rhinitis 
(hay fever) (Biedermann et al. 1999).  
Atopic eczema (AE) is an immune-mediated inflammatory skin disease (Biedermann et al. 1999) 
characterized by a defective skin barrier (Kliegman et al. 2011). Mainly younger children are affected 
(Leung 2003; Kliegman et al. 2011). While in industrialized countries 15 to 30% of children develop 
AE about 2 to 10% of adults suffer from the disease (Bieber 2008). AE patients present with intense 
pruritus and cutaneous reactivity, especially on the face, scalp and extremities. The chronic phase is 
characterized by lichenification or thickening of the skin (Kliegman et al. 2011). 
Currently, 235 million people suffer from asthma worldwide. It is the most common chronic disease 
among children (WHO 2011) causing significant morbidity (Kliegman et al. 2011). Allergic asthma is 
a chronic inflammatory disease of the bronchial airways that results in episodic airflow obstruction. 
The clinical symptoms include wheeze, cough and shortness of breath. Allergic asthma commonly 
reveals its onset early in childhood and often persists in adulthood (Leung 2003; Kliegman et al. 
2011). Although the cause of the disease is not clear to date, it has been associated with environmental 
exposures combined with inherent biologic and genetic susceptibilities (Kliegman et al. 2011). 
Allergic rhinitis, also known as hay fever, is an allergic reaction in the nasal mucosa that causes nasal 
congestion, runny nose, itching and often conjunctival irritation and sneezing (Kliegman et al. 2011). 
About 10 to 20% of the global population are affected by allergic rhinitis (Brozek et al. 2010) which 
commonly begins in childhood but often develops in early adulthood (Leung 2003). The severity of 
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the disease is more pronounced in adults in their twenties and thirties (Biedermann et al. 1999). 
Allergic rhinitis can be elicited by either seasonal allergens including tree pollens or perennial 
allergens such as house dust mite. However, atopic diseases are often related and nearly 80% of 
infants with atopic eczema subsequently develop hay fever or asthma later in childhood (Leung 2003). 
 
1.2 Immune regulation of atopic diseases 
Atopic diseases (ADs) share similar mechanisms of allergic tissue inflammation but target different 
organs including the skin, lung and nasal mucosa. Several components of the immune system are 
involved in the development of ADs including T cells, antigen-presenting cells (APCs), IgE 
production, eosinophils and mast cells (Kliegman et al. 2011). 
 
1.2.1 Immune regulation of atopic eczema 
Atopic eczema (AE) patients may reveal two types of skin lesions due to inflammation: acute or 
chronic. Skin lesions observed in AE patients are a consequence of secretion of proinflammatory 
cytokines and chemokines by local tissue leading to extravasation of inflammatory cells. T heper (Th) 
cells, including Th1 and Th2 cells, play a crucial role in this inflammatory process. While cytokines 
released by Th2 cells are involved in both forms, Th1 cytokines are only increased in chronic skin 
lesions (Leung 2003; Kliegman et al. 2011). Inflammatory cells are attracted by chemokines to the 
sites of injury leading to accumulation of eosinophils, macrophages and Th2 cells in these regions 
(Kliegman et al. 2011).  
Acute AE is characterized by an increased intercellular edema of the epidermis. APCs and 
macrophages coated with IgE are key in presenting the allergen to Th2 cells. In general, mast cells are 
found in normal numbers but at different stages of degranulation and an increase of perivenular T cell 
infiltrate is observed in the skin.  
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In contrast, chronic AE is characterized by a lichenified skin with hyperkeratosis, hyperplastic 
epidermis and minimal edema. IgE-coated Langerhans cells, dendritic APCs in the epidermis, 
accumulate in this region and macrophages in the dermal mononuclear cell infiltrate. Both, eosinophils 
and mast cells, reveal increased cell numbers. Hence, mast cells are degranulated and eosinophils 
release mediators causing tissue injury (Leung 2003; Kliegman et al. 2011). The chronic inflammatory 
response leads to tissue remodelling and fibrosis (Murphy et al. 2008; Kliegman et al. 2011). 
 
1.2.2 Immune regulation of allergic asthma 
In allergic asthma the presence of an allergen in the lower airways induces the activation of 
submucosal mast cells. Subsequently, an infiltration of exudates containing high amounts of 
eosinophils and other cell types including monocytes, lymphocytes, neutrophils, mast cells and 
basophils is induced (Kliegman et al. 2011). Th cells and other immune cells are activated to produce 
proinflammatory cytokines including IL-4, IL-5 and IL-13 and chemokines (Kliegman et al. 2011) 
which lead to the constriction of the bronchial tree and to an excessive production of mucus (Murphy 
et al. 2008). The continuous presence of proinflammatory molecules causes chronic inflammation of 
the lung and airway remodelling (Murphy et al. 2008). 
 
1.2.3 Immune regulation of allergic rhinitis 
The manifestation of allergic rhinitis is divided in two phases. In the early phase the contact of 
allergen with the IgE-coated mast cells leads to their degranulation (Leung 2003; Kliegman et al. 
2011). The released mediators promote the adhesion of circulating leukocytes to the endothelial cells, 
whereas the respective chemoattractant cytokines promote the infiltration of inflammatory cells 
(lymphocytes, macrophages, eosinophils, neutrophils and basophils) through the nasal mucosa (Leung 
2003; Kliegman et al. 2011). The late phase arises between 4 to 8 hours upon allergen exposure. While 
eosinophil released-mediators damage the epithelium, Th2 cells lead to an allergic response with an 
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increase in IgE production, mast cell recruitment and eosinophil chemoattraction (Leung 2003). It is 
very difficult to clinically differentiate the early- from the late-phase of allergic rhinitis (Leung 2003). 
 
Traditionally, ADs have been described as immune-mediated diseases with a higher prevalence of Th2 
cells, a subset involved in antibody switching to IgE (Biedermann et al. 1999). Yet, in AE both Th1 
and Th2 cells seem to play a role in the immunopathogenesis (Murphy et al. 2008), suggesting that the 
immune mechanisms involved in atopy per se may differ depending on which type of AD is 
developed. Nevertheless, this pattern may be too simple and recent evidence suggests that other T cell 
subsets such as regulatory T cells (Treg) and Th17 cells are involved in the immunopathogenesis of 
ADs (Kliegman et al. 2011). However, the specific role of these T cell subsets in the development and 
persistence of these diseases is not fully understood to date. To increase the knowledge in this field, 
potential influences that can modulate the development of ADs need to be considered including 
genetic predisposition and changes in environmental factors (Kliegman et al. 2011). 
 
1.2.4 The function of T cell subsets  
1.2.4.1 The function of Th1 and Th2 cells  
The T cell subsets - Th1 and Th2 - were first described in 1986 (Mosmann et al. 1986). In the early 
’90s several evidences suggested the importance of Th2 cells in ADs (Romagnani 1994).  
The effector functions of Th1 cells include activation of infected macrophages, clearance of 
intracellular pathogens and support of B cells to produce antibody isotypes. Th2 cell functions include 
promoting IgE production by B cells and activation of eosinophils that serve to eradicate helminthic 
infections (Murphy et al. 2008; Korn et al. 2009; Abbas et al. 2012). IFN- and IL-12 are required for 
Th1 differentiation while IL-4 triggers the differentiation of Th2 cells. Both T cell subsets express 
certain transcription factors (TFs) after their activation including T-bet (Th1) and GATA-3 and STAT6 
(Th2). Th1 cells secrete high amounts of IFN-andTh2 cells are characterized by the secretion of IL-
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4, IL-5, IL-10 and IL-13 (Murphy et al. 2008). The differentiation of both subsets is mutually 
exclusive since IFN- and IL-4 antagonize each other on different levels (Korn et al. 2009). 
 
1.2.4.2 The function of regulatory T cells 
Although the existence of a suppressor T cell was already suggested in the 1970s, regulatory T (Treg) 
cells were only distinguished in the late ’90s. Within the past decade several types of Treg cells were 
identified, suggesting that this T cell subpopulation is a heterogeneous group of T cells with immune 
regulatory properties and different developmental origins (Murphy et al. 2008; Sakaguchi et al. 2010).  
Natural Treg cells (nTreg) are produced in the thymus. These CD4
+
 T cells express high amounts of 
surface CD25 (IL-2 receptor) and the intracellular transcription factor FOXP3. When activated, nTregs 
secrete IL-10 and TGF-(Murphy et al. 2008). They are anergic cells with suppressive capacity 
(Shevach 2006). 
Other T cell populations also possess regulatory activity, named adaptive or induced regulatory T cells 
(iTregs). These iTregs are committed to a regulatory fate in the periphery following specific antigenic 
stimulation (Sakaguchi et al. 2010). This subset of cells encompasses IL-10-secreting Tr1 cells, TGF-
-secreting Th3 cells, and certain subsets of CD8
+
 and CD4
-
CD8
-
 T cells that have previously also 
been related to adaptive regulatory functions (Shevach 2006; Sakaguchi et al. 2010). Th3 cells are 
produced in the mucosa and have been shown to play a role in oral tolerance (Murphy et al. 2008). In 
contrast, Tr1 cells are antigen-specific cells controlling inflammation and collateral tissue damage 
(Shevach 2006). Both subsets of T cells do not express FOXP3 (Curotto de Lafaille et al. 2009). 
CD4
+
CD25
high
 and CD4
+
CD25
high
FOXP3
+
 are used as descriptive markers for nTregs. Nevertheless, 
some Treg cells express “intermediate” amounts of CD25 and activated effector T cells can also 
express high amounts of CD25 and even transiently FOXP3 without being anergic or suppressive 
(Shevach 2006). Other markers are used to delineate the specificity of Treg cells in addition to 
CD4
+
CD25
high
, including low expression of IL-7 receptor (CD127
low/-
), expression of CTLA-4 or 
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GITR. As these markers are also expressed by other activated effector T cells (Shevach 2006), the 
suppressive capacity is the most specific factor to identify a functional nTreg cell to date.  
In the last years the methylation status of CpG motifs in FOXP3 was demonstrated as a reliable 
marker for Treg cells in adults and mice (Baron et al. 2007; Floess et al. 2007). An evolutionary 
conserved region upstream from exon 1 with transcriptional activity, named Treg-specific 
demethylated region (TSDR), was identified. This TSDR region was fully demethylated specifically in 
nTregs but not in CD4
+
CD25
-
 T cells, in vitro induced FOXP3
+
 Treg cells or transiently activated 
FOXP3
+
 T cells (Baron et al. 2007; Floess et al. 2007). 
 
1.2.4.3 The function of Th17 cells 
In contrast to Treg cells, Th17 cells are important for the host defense against extracellular bacteria. 
However, the pathogenesis of some immune-mediated diseases including ADs is also regulated by this 
T cell subset population (Stockinger et al. 2007; McGeachy et al. 2008; Cosmi et al. 2011). 
The main transcription factors of human Th17 cells are RORC2 (also known as RORC isoform b) and 
ROR (Korn et al. 2009) Other transcription factors, including STAT3 and aryl hydrocarbon receptor 
(AHR), also play an important role in Th17 cell regulation (Dong 2011). The cytokine milieu required 
for Th17 cell differentiation comprises TGF-, IL-6, IL-21, IL-1 and IL-23 (Volpe et al. 2008; Korn 
et al. 2009). However, the latter cytokine and its receptor, IL-23R, have been suggested to be required 
for stabilization and commitment to the Th17-lineage rather than for differentiation (Korn et al. 2009). 
Th17 cells themselves characteristically secrete IL-17A, IL-17F, IL-21, IL-22 and IL-26 (Korn et al. 
2009). 
Th17 cells show an apparent plasticity and the T cell subset has been related to Th1, Th2 and Treg 
cells. Indeed, IFN-
+
IL-17
+
 T cells have been detected in human tissues expressing both RORC2 and 
T-bet (Annunziato et al. 2007); IL-17
+
IL-4
+
 T cells were also produced by T cell clones of human 
circulating T cells (Cosmi et al. 2010). Furthermore, in vivo studies demonstrated that Treg cells can 
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adopt a Th17-like phenotype in the periphery, expressing IL-17, FOXP3 and RORC2 with suppressive 
function (Voo et al. 2009). Although the basis for this flexibility on maintenance and reprogramming 
the T cell fate are not clear yet, epigenetic modifications may potentially be involved (Dong 2011). 
 
1.2.5 Role of regulatory T cells and Th17 cells in atopic diseases 
1.2.5.1 Regulatory T cells in atopic diseases 
Several studies suggest that an altered number or function of Treg cells may contribute to the 
exacerbated immune response observed in atopic individuals. However, present data is contradictory 
and the underlying mechanisms remain unclear (Ryanna et al. 2009). A deficiency in Treg suppression 
activity was observed in atopic subjects compared to non-atopic controls (Ling et al. 2004). In this 
study Treg cell function was even further impaired in individuals suffering from hay fever during the 
pollen season. Shi et al. reported increased Treg cell numbers in atopic asthmatics during acute 
exacerbation compared to controls, yet with similar Treg suppressive function in both groups (Shi et 
al. 2004). Treg cell numbers were also increased in peripheral blood mononuclear cells (PBMCs) of 
AE patients compared to asthmatics (Ou et al. 2004) and healthy controls (Ou et al. 2004; Hijnen et al. 
2009). Similar suppressive activity was observed in all groups (Ou et al. 2004) and Treg cells were 
present in atopic skin lesions (Honda et al. 2011). Recently, similar Treg cell numbers were observed 
in asthmatic adults compared to controls, but FOXP3 expression of CD4
+
CD25
high
 cells was impaired 
in asthmatics (Provoost et al. 2009). 
Treg cells are relevant in the immune homeostasis. During immune maturation - a time window where 
the immune system is more susceptible to external influences - Treg cells may therefore contribute to 
the development of ADs (Lloyd et al. 2009). Maternal atopy is a known risk factor for the 
development of atopic diseases in childhood (Liu et al. 2003; Moore et al. 2004). In cord blood of 
atopic mothers, Treg cells were already impaired in respect to numbers and function in such an early 
stage of immune maturation (Schaub et al. 2008). While Treg cells were decreased and less 
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suppressive in the airways, in peripheral blood of asthmatic children compared to healthy controls no 
change was observed (Hartl et al. 2007). Interestingly, inhaled corticosteroid treatment increased Treg 
cell numbers and restored their function in asthmatic patients (Hartl et al. 2007). 
Thus, Treg cells seem to be involved in ADs but results between studies have been inconsistent. This 
may be due to two reasons i) some of the studies defined Treg cells based on CD4 and CD25 
expression but did not include FOXP3 as a marker. Therefore, the population under study may 
potentially have included activated T cells; and ii) the majority of the studies assessed Treg cells in 
peripheral blood, which may not reflect the actual active location of disease (Ryanna et al. 2009). 
 
1.2.5.2 Th17 cells in atopic diseases 
In addition to Tregs, Th17 cells have also been related to ADs. In fact, Th17 cell levels were increased 
in peripheral blood of AE patients and were associated with the severity of AE (Koga et al. 2008). 
Immunohistochemistry analyses demonstrated that IL-17
+
 cells were mostly increased in acute but not 
in chronic skin lesions (Toda et al. 2003; Koga et al. 2008). IL-17 levels were increased in serum of 
severe birch allergy patients out of the pollen season (Ciprandi et al. 2008) and were highly correlated 
with clinical symptoms and eosinophil counts in allergic rhinitis patients during the pollen season 
(Ciprandi et al. 2009). 
Elevated IL-17 protein levels were found in sputum and bronchoalveolar lavage fluids (BALF) of 
asthmatic patients (Molet et al. 2001) and in plasma of allergic asthmatics (Wong et al. 2001). The 
secretion of IL-17 was also shown to be related to bronchial hyperreactivity (Barczyk et al. 2003). 
Furthermore, a positive relationship between increased Th17 cell numbers in peripheral blood and 
allergic asthma severity has been observed (Zhao et al. 2010). Consistent with previous findings, IL-
17 and IL-17F, another cytokine secreted by Th17 cells, were elevated in lung tissues of severe 
asthmatics (Al-Ramli et al. 2009). Other studies suggested that higher IL-17 in bronchial airways 
(Chakir et al. 2003) and in sputum (Bullens et al. 2006) is related to asthma severity and to 
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neutrophilic inflammation (Bullens et al. 2006; Alcorn et al. 2010). Neutrophilia correlates with 
asthma severity and is enhanced in non-eosinophilic non-atopic asthmatics (Alcorn et al. 2010). 
Furthermore, IL-17 can lead to elevated IL-8, a neutrophilic chemoattractant that recruits and activates 
neutrophils (Linden 2001; Bullens et al. 2006). Thus, Th17 cells are suggested to be a key player in 
the pathogenesis of severe neutrophilic asthma (Alcorn et al. 2010).  
Little is known about Th17 cells during immune maturation in respect to the development of ADs. IL-
17 protein was expressed in cord blood at very low levels independent of maternal atopy (Schaub et al. 
2008). Others showed increased levels of IL-17 and IL-22 mRNA expression in PBMCs of rhinitis and 
asymptomatic atopic school-age children. In asthmatic children Farfariello et al. were unable to 
confirm the gene expression of IL-17 (Farfariello et al. 2011). However, IL-22 mRNA levels were 
increased and correlated directly to disease severity in both asthmatic and rhinitis patients (Farfariello 
et al. 2011). 
In summary, Th17 cells are involved in the inflammatory process and/or immunopathogenesis of ADs. 
Differences exist depending on the disease, e.g. in AE Th17 cells are detected during acute skin 
lesions while in asthma they are rather involved in the more severe cases. The specific role of Th17 
cells in the immune regulation of these diseases and the underlying mechanisms are still unknown and 
further investigations are required.  
 
 
1.3 Impact of environmental factors on the development of atopic 
diseases 
ADs are complex multifactorial diseases influenced by environmental factors (Bach 2002).  
Maternal atopy is known as a risk factor for the development of ADs in childhood, whereas paternal 
atopy may have a rather minor influence on its manifestation (Liu et al. 2003; Moore et al. 2004). 
Since the genetic contribution of parental atopy is expected to be equivalent between both parents, the 
1. INTRODUCTION 
 
 
- 10 - 
date suggests that the effect of maternal atopy on the risk of developing ADs in childhood surpasses 
genetic predisposition. Hence, the maternal immune status during pregnancy, affecting the 
environment in utero, may subsequently have an impact on the child’s immune development (Schaub 
et al. 2008).  
In contrast to maternal atopy, maternal farming exposures and growing up on a farm are protective 
factors for the development of ADs (von Mutius et al. 2010; Lluis et al. 2012), a phenomenon known 
as the “farm effect”. Living on a farm often involves the exposure to farm-related components that 
may modulate the child’s immune system towards an “allergy-protective” status. Several of these 
farm-related exposures have been shown to influence the risk for ADs including microbes (Braun-
Fahrlander et al. 2002; Debarry et al. 2010; Ege et al. 2011) and grass arabinogalactans  (Peters et al. 
2010), farm milk consumption (Riedler et al. 2001; Waser et al. 2007; Loss et al. 2011), staying in 
stables (Riedler et al. 2001) or contact to hay (Ege et al. 2007). 
The length of exposure to these environmental factors is important for their influence on the immune 
system and its subsequent risk of developing ADs. In utero and in early life exposures - a time 
window when the immune system is immature and is more susceptible to external influences - are of 
special relevance (von Mutius et al. 2010; Lluis et al. 2012). Regarding the “farm effect”, contact to 
stables and to farm milk consumption before the first year of life showed a stronger protective effect 
against development of ADs than children exposed between year 1 and 5 (Riedler et al. 2001). 
Maternal exposure to animal sheds during pregnancy was associated with lower IgE production 
against seasonal allergens already in cord blood (Ege et al. 2008) and maternal contact to cats and 
farm animals was also associated with lower risk of AE early in life (Roduit et al. 2011).  
Thus, the influence on immune regulation also depends on the type of environmental exposure. 
Maternal atopy decreased Treg cell numbers and function in cord blood per se (Schaub et al. 2008). 
When maternal farm exposure was taken into account an association with higher and more efficient 
Treg cells (Schaub et al. 2009) and increased Th1-associated cytokines (Pfefferle et al. 2010) in cord 
blood was observed. Exposure to farming environment also increased expression of innate receptors in 
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cord blood (Roduit et al. 2011) and in school-age children (Lauener et al. 2002; Ege et al. 2006). 
Indeed, prenatal exposure to stables rather than current exposures increased TLR2/TLR4/CD14 
expression in school age children (Ege et al. 2006). 
Hence, environmental factors are a key factor for the risk of developing ADs, with stronger influence 
in early stages of immune maturation.  
 
1.4 Impact of genetic predisposition on the development of atopic 
diseases 
In addition to environmental factors, ADs are influenced by genetic predisposition. Several studies 
demonstrated that specific polymorphisms within the Th1 and Th2 pathways can influence the risk to 
develop ADs (Cameron et al. 2006; Schedel et al. 2008; Schedel et al. 2009; Suttner et al. 2009). 
In the last years, Genome Wide Association Studies (GWAS) became a powerful tool to further 
understand the impact of specific polymorphisms on several complex diseases. For childhood asthma, 
two GWAS revealed a potential role for genetic variants of the 17q21 locus including IKZF3, ZPBP2, 
GSDMB, ORMDL3, and GSDMA (Moffatt et al. 2007; Moffatt et al. 2010). The association signal of 
17q21 has been confirmed by many different studies (Moffatt et al. 2007; Bouzigon et al. 2008; 
Verlaan et al. 2009; Halapi et al. 2010; Moffatt et al. 2010) selectively for childhood (Moffatt et al. 
2010). A further characterization revealed that asthma-associated polymorphisms within 17q21 
influenced transcription levels of ORMDL3 (Moffatt et al. 2007; Verlaan et al. 2009; Halapi et al. 
2010) and  GSDMB, (Verlaan et al. 2009; Halapi et al. 2010). However, the functional role of these 
genes in asthma development remains to be unravelled. The current challenge is to further understand 
the role of these genes, how can they affect immune regulation and subsequently influence disease 
development. 
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1.5 Aims 
Much attention has been given to the Th1/Th2 unbalance in the development of atopic diseases(ADs). 
However, other T cell subsets including regulatory T (Treg) and Th17 cells have been shown to be 
involved in its pathophysiology. To date little is known about the underlying mechanisms implicated 
in the development and persistence of these diseases. Studying the behaviour of these T cell subsets 
during immune maturation, a period in which the immune system is more susceptible to external 
influences, is of special interest to gain knowledge on the immunopathogenesis of ADs. 
The aim of the present study was to investigate the functional role of Treg and Th17 cells in relation to 
the development of ADs in childhood. In this context, several cross-sectional studies have 
demonstrated that farming lifestyle is a protective factor for the development of ADs in childhood. 
Maternal farming was associated with increased Treg cell numbers and higher suppressive capacity 
already at birth. In addition, specific maternal farm exposures were associated with FOXP3 
demethylation in the Treg-specific demethylated region (TSDR) in cord blood.  
The following scientific questions are still open and were therefore addressed in this thesis: 
1) To study whether FOXP3 demethylation at the TSDR, shown as good and reliable natural Treg 
(nTreg) marker used in adults and mice, was an appropriate parameter to assess nTreg cell activity 
also in cord blood. 
2) To investigate whether the differences observed in number and function of cord blood Treg cells 
from farming and non-farming families are persistent later in childhood and whether they may have an 
impact on the development of atopic diseases in a farming population at age 4.5 years.  
3) To investigate whether Th17 cells, a cell population increased in atopic diseases, was influenced by 
maternal farm exposure, a known “allergy-protective” environment, in cord blood.  
4) To study whether single nucleotide polymorphisms (SNPs) within the Th17-lineage pathway may 
have an influence on cord blood T cell subsets. 
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5) To investigate whether the previously described asthma-associated SNPs within the 17q21 region 
may influence T cell subsets and mRNA expression of genes located within the 17q21 region in cord 
blood. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Reagents and chemicals  
100bp ladder (500μg/mL)    New England BioLabs, Ipswich, USA 
ACK Lysis Buffer    Cambrex, East Rutherford, USA 
Anti-human CD3-PE antibody   Beckmann Coulter, Fullerton, USA 
Anti-human CD4-FITC antibody   BD Pharmingen, Franklin Lakes, USA 
Anti-human CD4-FITC antibody   Beckmann Coulter, Fullerton, USA 
Anti-human CD25-APC antibody   BD Pharmingen, Franklin Lakes, USA 
Anti-human CD25-PC5 antibody   Beckmann Coulter, Fullerton, USA 
Anti-human CD127-PE antibody   eBioscience, San Diego, USA 
Anti-human FOXP3-PE antibody   BD Pharmingen, Franklin Lakes, USA 
Anti-human FOXP3-PE antibody   eBioscience, San Diego, USA 
Anti-human IgG1-FITC antibody   Dako Cytomation, Glostrup, Denmark 
Anti-human IgG1-PE antibody   BD Pharmingen, Franklin Lakes, USA  
Anti-human IgG1-PE antibody   Dako Cytomation, Glostrup, Denmark 
Anti-human IgG2a-PC5 antibody   Beckmann Coulter, Fullerton, USA  
Anti-human IgG2a-PE antibody   eBioscience, San Diego, USA 
Bioplex Sheath Fluid    Biorad, Hercules, USA 
Boric acid     Sigma-Aldrich, Steinheim, Germany 
Bovine Serum Albumin (BSA)   Sigma-Aldrich, Steinheim, Germany  
Bromophenol blue    Roth, Karlsruhe, Germany 
D. pteronyssinus allergen 1 (Derp1)  Indoor Biotechnologies, Charlottesville, USA 
Ethanol 100%     Merck, Darmstadt, Germany 
Ethidiumbromide (10mg/mL)   Biorad, Hercules, USA 
Ethylene diamine tetraacetic acid EDTA (0.5M) Sigma-Aldrich, Steinheim, Germany 
FACS Clean Solution     BD Biosciences, Heidelberg, Germany 
FACS Flow™ Sheath Fluid   BD Biosciences, Heidelberg, Germany 
FACS Rinse Solution    BD Biosciences, Heidelberg, Germany 
Ficoll-Paque™ PLUS    GE Healthcare, Piscataway, USA 
Fixation/Permeabilization Concentrate  eBioscience, San Diego, USA 
Fixation/Permeabilization Diluent   eBioscience, San Diego, USA 
Fluorescein Calibration Dye   Biorad, Hercules, USA 
Fetal Bovine Serum Gold (FCS)   PAA Laboratories GmbH, Pasching, Austria 
Glycerol     Sigma-Aldrich, Steinheim, Germany 
H2O bidest.     H. Kerndl GmbH, Weißenfeld, Germany 
Human serum     Sigma-Aldrich, Steinheim, Germany 
Hydrogen chloride (HCL)    Sigma-Aldrich, Steinheim, Germany 
Ionomycin     Sigma-Aldrich, Steinheim, Germany 
Isopropanol 100%    Merck, Darmstadt, Germany 
Lambda DNA     New England BioLabs, Ipswich, USA 
LiChrosolv H2O (HPLC)    Merck, Darmstadt, Germany 
Liquemin N 7500 (Na-Hep)   Roche Diagnostics, Mannheim, Germany 
Lipid A      Sigma-Aldrich, Steinheim, Germany 
Lipopolysaccharide    Sigma-Aldrich, Steinheim, Germany 
Nuclease-free water    Ambion, Austin, USA 
Paraformaldehyde    Sigma-Aldrich, Steinheim, Germany 
PBS with EDTA (2mM)    Apotheke Innenstadt Uni München, Munich, Germany 
Penicillin/Streptomycin    Gibco, Carlsbad, USA 
Peptidoglycan     Sigma-Aldrich, Steinheim, Germany 
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Permeabilization Buffer (10X)   eBioscience, San Diego, USA 
Phosphate-Buffered Saline (PBS)    Gibco, Carlsbad, USA 
Phorbol 12-myristate 13-acetate (PMA)  Sigma-Aldrich, Steinheim, Germany 
Phytohemagglutinin    Sigma-Aldrich, Steinheim, Germany 
Primers      Invitrogen, Carlsbad, USA 
Rat serum     eBioscience, San Diego, USA 
Rotiszint® eco (LSC-Universalcocktail)  Carl Roth, Karlsruhe, Germany 
RPMI 1640 + GlutaMax    Gibco, Carlsbad, USA    
Sodium hydroxide (NaOH)    Sigma-Aldrich, Steinheim, Germany 
Trypan Blue     Sigma-Aldrich, Steinheim, Germany 
Tritium Methyl-H3-Thymidin   Amersham, Piscataway, USA  
Trizma Base       Sigma-Aldrich, Steinheim, Germany 
TRIzol Reagent     Invitrogen, Carlsbad, USA 
Tween 20     Merck, Darmstadt, Germany 
Water DEPC (0.1 %)    Serva Electrophoresis GmbH, Heidelberg, Germany 
Water, Mol Bio grade    5 Prime, Gaithersburg, USA 
Xylene cyanol     Merck, Darmstadt, Germany 
 
2.1.2 Solutions and buffers 
1% PFA      10g paraformaldehyde 
      Ad 900mL ddH2O 
      800μl 1N NaOH 
      30 min at 65°C 
      100mL PBS 10X until pH 7.4 
5.5% BSA     5.5g Bovine Serum Albumin 
      100mL PBS with EDTA (2mM) 
5X TBE buffer     54g Trizma Base 
      27.5g boric acid 
      20mL 0.5M EDTA (pH 8.0) 
      Ad 1l H2O bidest. 
DNA ladder     10μl 100bp ladder 
      80μl 0.5x TBE-Buffer 
      10μl Loading Dye 
Ethidiumbromide (500μg/mL)   100μl Ethidiumbromide 
      1900μl dH2O  
FACS buffer     25mL 10X PBS 
      Ad 250mL LiChrosolv H2O 
      12.5mL FCS (5%) 
      1.25mL Tween 20 (0.5%)   
Isolation buffer (0.55% BSA)   40mL PBS with EDTA (2mM) 
4mL 5.5% BSA      
Loading dye diluted solution   5mL Loading dye stock solution 
      13.5mL glycerol 
      31.5mL dH2O 
Loading dye stock solution   0.25g bromophenol blue 
      0.25g xylene cyanol   
      30% glycerol 
      70mL dH2O 
Medium 10% human serum   440mL RPMI 1640 + GlutaMAX 
      10mL Penicillin/Streptomycin  
      50mL inactivated human serum 
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2.1.3 Reagent systems (Kits) 
Allergy Screen test panel for atopy   Mediwiss Analytic, Moers, Germany 
CellTrace™ CFSE Cell Proliferation Kit  Invitrogen, Carlsbad, USA 
CD3 MicroBeads    Miltenyi Biotec, Bergisch Gladbach, Germany 
CD4+CD25+ Regulatory T Cell Isolation Kit Miltenyi Biotec, Bergisch Gladbach, Germany 
FlexiGene DNA Kit     Qiagen, Hilden, Germany 
Human Cytokine Multiplex Assay Kit  Biorad, Hercules, USA 
Human FoxP3 Buffer Set     BD Pharmingen, Franklin Lakes, USA 
QIAamp DNA Micro Kit    Qiagen, Hilden, Germany 
QuantiTect Rev. Transcription Kit  Qiagen, Hilden, Germany 
Roche LightCycler® 480 Probes Master  Roche Diagnostics, Mannheim, Germany 
SYBR Green PCR Master Mix   Applied Biosystems, Foster City, USA 
 
2.1.4 Consumables 
Filter Mat Glass Fiber Paper   Skatron Instruments, Lier, Norway 
iQ™ 96-Well PCR Plates     Biorad, Hercules, USA 
Biosphere® filter tips 10µL M 40mm type D Sarstedt, Nümbrecht, Germany 
Biosphere® filter tips 100µL     Sarstedt, Nümbrecht, Germany 
BZO Adhesive Optical Seal Film   Biozym Scientific, Hessisch Oldendorf, Germany 
LD columns     Miltenyi Biotec, Bergisch Gladbach, Germany 
LS columns     Miltenyi Biotec, Bergisch Gladbach, Germany 
Microtest™ 96 well plates   BD Biosciences, Heidelberg, Germany 
MS columns     Miltenyi Biotec, Bergisch Gladbach, Germany 
Multiwell™ 6 well plates    BD Biosciences, Heidelberg, Germany 
SafeGuard Filter tips 100-1000µL  Peqlab, Erlangen, Germany 
Serum-Gel S-Monovette     Sarstedt Nümbrecht, Germany 
S-Monovette      Sarstedt Nümbrecht, Germany 
Zinsser polyvials (liquid scintillation)  Zinsser Analytic, Frankfurt am Main, Germany 
 
2.1.5 Laboratory equipment 
Additionally to the standard laboratory equipment the following devices were used: 
Beta Counter LS 6000IC     Beckman Coulter, Fullerton, USA 
Centrifuge 5810 R / 5417 R / 5415 R   Eppendorf, Hamburg, Germany 
Centrifuge Rotanta 460R / S   Hettich, Tuttlingen, Germany 
Combi cell harvester     Skatron Instruments, Lier, Norway 
Electrophoresis Power Supply    VWR International, Radnor, USA 
FACS MoFlo XDP    Beckman Coulter, Fullerton, USA 
FACSCalibur     Becton-Dickinson, Heidelberg, Germany 
FACScan     Becton-Dickinson, Heidelberg, Germany 
Gel iX Imager     Intas Science Images Instruments, Göttingen, Germany 
iCycler iQ™ Real Time PCR Detection System  Biorad, Hercules, USA 
Incubator Hera Cell 240     Hereus, Hanau, Germany 
Incubator Heraeus 6000    Heraeus, Hanau, Germany  
LUMINEX 100 IS System    Luminex Corp., Austin, USA 
MACS® MultiStand    Miltenyi Biotec, Bergisch Gladbach, Germany 
Micro Centrifuge II     NeoLab, Heidelberg, Germany 
Microplate shaker Type Rotamax 120  Heidolph Instruments, Schwabach, Germany 
Microscope Axiovert 40C    Zeiss, Göttingen, Germany 
Microwave      Siemens, Munich, Germany 
MidiMACS™ Separator    Miltenyi Biotec, Bergisch Gladbach, Germany 
MiniMACS™ Separator    Miltenyi Biotec, Bergisch Gladbach, Germany 
MoFlo XDP     Beckmann Coulter, Fullerton, USA 
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Neubauer cell counter    Karl Hecht KG Assistent, Sondheim, Germany 
Owl D3-14 Wide Gel System   Thermo Scientific, Waltham, USA 
Roche LightCycler 480 System   Roche Diagnostics, Mannheim, Germany 
Sterile Hood LaminAir HBB2472   Heraeus, Hanau, Germany 
Thermocycler Eppendorf Mastercycler   Eppendorf, Hamburg, Germany 
Vacuum regulator    Biorad, Hercules, USA  
Vortex Genie 2     Scientific Industries, Bohemia, USA 
Waterbath Köttermann     Köttermann GmbH, Uelze, Germany 
 
2.1.6 Software 
Adobe Photoshop    Adobe Systems, Edinburgh, UK 
Bio-plex Manager Software 4.1   Biorad, Hercules, USA 
Cell Quest Software    Becton-Dickinson, Heidelberg, Germany 
Cell Quest Pro Software    Becton-Dickinson, Heidelberg, Germany 
CHIP Bioinformatics Tools    http://snpper.chip.org/bio/ 
EndNote X3     ISI ResearchSoft, Berkeley, USA 
Ensembl Genome Browser   http://www.ensembl.org/ 
FCS express v3     De Novo Software, Los Angeles, USA 
Haploview     http://www.broad.mit.edu/mpg/haploview/ 
iCycler iQ Optical System Software v3.1  Biorad, Hercules, USA 
International Hapmap Project   http://hapmap.ncbi.nlm.nih.gov 
Microsoft Office     Microsoft, Redmont, USA 
National Center for Biotechnology Information  http://www.ncbi.nlm.nih.gov/ 
SAS software package version 9.2   SAS Institute, Cary, USA 
Sigmastat version 1.0    Systat Software Inc., Chicago, USA 
Vector NTI 10     Invitrogen, Carlsbad, USA  
Vertebrate Genome Annotation (VEGA) database http://vega.sanger.ac.uk/ 
WinMDI 2.8     The Scripps Research Institute, La Jolla, USA 
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2.2 Methods 
2.2.1 Subject recruitment 
2.2.1.1 Characteristics of birth cohort studies 
Two birth cohorts were used for the present study: the PAULINA (Schaub et al. 2008) and the 
PAULCHEN (Schaub et al. 2009) Study. Analyses of cord blood Th17 cells in a farming population 
and genetic polymorphisms within the Th17-lineage genes were assessed in the PAULCHEN cohort. 
The rest of the investigations, including regulatory T cell (Treg) demethylation and 17q21 genetic 
polymorphism analyses, were based on a combined dataset of both study populations.  
 
2.2.1.1.1 The PAULINA Study (Paediatric Alliance for Unselected Longitudinal Investigation of 
Neonates for Allergies) 
Cord blood of 161 children was collected in Munich, Germany (Schaub et al. 2008). Enrolment 
occurred from January 2005 until February 2007. Pregnant mothers were approached before delivery 
for consent and completed a detailed questionnaire assessing maternal and infant data. Inclusion 
criteria comprised healthy neonates and mothers with uncomplicated pregnancies. Exclusion criteria 
included preterm deliveries, multiple gestations, perinatal infections, fever around birth, maternal 
intake of medication and maternal chronic diseases. Approval was obtained from the local review 
board (Bavarian Ethical Board), Germany.  
 
2.2.1.1.1.1      Questionnaire 
Through the questionnaire potential covariates including sex, birth characteristics, race/ethnicity, 
siblings, maternal education, maternal smoking, parental atopic status and medication used by the 
parents were assessed. Maternal and paternal atopic status was determined as the presence or absence 
of an allergic illness through a doctor’s diagnosis of asthma and/or eczema and/or hay fever (Schaub et 
al. 2008). 
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2.2.1.1.2 The PAULCHEN Study (Prospective Cord Blood Study in Rural Southern Germany) 
84 pregnant mothers from rural southern Germany were enrolled in the study from July 2005 until 
September 2007 before birth (Schaub et al. 2009). Inclusion and exclusion criteria as well as potential 
covariates were equivalent to the PAULINA Study (See point 2.2.1.1.1). 82 cord blood samples were 
included in the study as they fulfilled all quality criteria. Informed consent was obtained from mothers 
for participation in the study, including cord blood collection. Approval was obtained from the local 
review board (Bavarian Ethical Board), Germany.  
 
2.2.1.1.2.1      Questionnaire 
Potential covariates were assessed by questionnaire including sex, birth characteristics, race/ethnicity, 
marital status of the mother, maternal education, maternal smoking, parental atopic status and 
medication used by the parents, siblings and atopic diseases of the siblings. Atopic status was 
determined as the presence or absence of an allergic illness through a doctor’s diagnosis of asthma 
and/or eczema and/or hay fever (Schaub et al. 2009). 
Furthermore, mothers completed a detailed questionnaire regarding rural lifestyle and farm-related 
exposures. Questions comprised whether mothers lived on a farm, if they ran and actively worked on 
the farm, which kind and numbers of farm animals lived on the farm, kind of fodder, specific farm-
related jobs performed, time spent in the stables and/or barns during pregnancy, contact to farm 
animals during pregnancy, farm milk consumption during pregnancy (boiled/unboiled), children and 
pets living in the house and whether the mothers lived on a farm during their childhood. Maternal farm 
exposure was defined as the mother living and regularly working on a farm in the last 1 to 5 years and 
during pregnancy. Non-farming mothers lived in the same rural area but not on a farm. 
 
2.2.1.1.3 The PASTURE/EFRAIM Study (Protection against allergy: Study in Rural Environments) 
This prospective birth cohort study included children from rural areas in 5 European countries 
(Austria, Finland, France, Germany and Switzerland) (von Mutius et al. 2006). In brief, women living 
in rural areas were contacted during pregnancy. Women who lived on family-run livestock farms were 
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assigned to the farm study group, while women from the same rural areas, but not living on a farm, 
were recruited as the reference group. 
The complete PASTURE/EFRAIM population consists of 1,133 children. For a subgroup of 325 
German or French children follow-up at the age of 4.5 years was selected for measurements of 
immunological markers at this age. Data on Treg cells was available from 298 children including 157 
German and 141 French children (91.7%). 27 children were excluded as not enough blood was 
available for the experiment or due to technical problems (Figure 1). According to the study design 
50% of the subjects were farm children. Table I shows prevalence of typical farm exposures, potential 
confounders and atopic sensitization at age 4. The study was approved by the local research ethics 
committees in each country, and written informed consent was obtained from all parents (Lluis, 
Depner et al. Manuscript submitted).  
 
 
Figure 1. Study design for assessement of Treg cells at age 4.5 years. 
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Table I. Prevalence of exposures, potential confounders and atopic sensitization at 4.5 years. 
 
A. 
 
 
B. 
 
 
C. 
 
 
#
 RAST class 3 ≥3.5IU/mL 
 
 
2.2.1.1.3.1 Questionnaire 
Parents completed questionnaires during pregnancy and at age 2, 12, 18, 24, 36, 48 months. The 
questions referred to the general health of the child and family, with focus on respiratory and ADs and 
different farm exposures. Questionnaires were based on items from previous studies including the 
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ALEX (Allergy and Endotoxin Study) (Riedler et al. 2001), the AMICS (Asthma Multicenter Infants 
Cohort Study) (Basagana et al. 2002), the PARSIFAL study (Prevention of Allergy Risk factors for 
Sensitization In children related to Farming and Anthroposophic Lifestyle) (Alfven et al. 2006), and 
questions derived from the ATS (American Thoracic Society) questionnaire (Ferris 1978). The study 
was approved by the local research ethics committees in each country, and written informed consent 
was obtained from all parents (von Mutius et al. 2006) (Lluis, Depner et al. Manuscript submitted).  
Farm children were defined by the study design as children whose parents answered positively to the 
question ‘does your child live on a farm?’ and whose family ran the farm. 
The analyses of farm-related exposures was primarily based on the questionnaire at age 4 years since 
Treg cell numbers were assessed at 4.5 years of age.  
Analyzed farm exposures included: 
a) Farm milk consumption. Children drinking at least once farm milk during the last twelve months 
were considered farm milk drinkers. Specific questions regarding farm/shop milk consumption and 
boiling status of consumed farm milk were also derived. Based on the questionnaire children were 
grouped into the following categories i) exclusive shop milk exposure, ii) mixed milk exposure 
(exposure to both shop and farm milk), and iii) exclusive farm milk exposure. The information on the 
boiling status of the milk drunken was used to subdivide the farm milk exposure into ‘only boiled farm 
milk drinkers and ‘any unboiled farm milk drinkers’. The latter included children consuming 
exclusively unboiled farm milk as well as those consuming both unboiled and boiled farm milk.  
For farm milk consumption an additional variable “farm milk in childhood” was defined in which 
children with farm milk consumption in the 2
nd
, 3
rd
 or 4
th
 year of life were stated as farm milk 
consumers during childhood while children who did not drink farm milk at that age were defined as 
the control group. A four-categorical variable showing the pattern of farm milk consumption in 
childhood and/or pregnancy was also created. 
b) Being in stables. Children with a single contact to the stable were classified as children with stable 
contact. 
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c) Regular contact to hay. The group included children that were at least once a week in contact with 
hay. 
Other relevant exposures were also assessed including type of farm (milkers, pigs, poultry or other 
animals), number of animal species, number of older siblings, maternal smoking during pregnancy, 
duration of breastfeeding and parental allergic status. Parental allergic status was defined as at least 
one of the parents suffering from asthma, allergic rhinitis and/or atopic eczema (Lluis, Depner et al. 
Manuscript submitted).  
 
2.2.1.2 Cord blood samples for methylation study of regulatory T cells and for stimulation 
study with retinoic acid  
Additional cord blood donors (N=25) were recruited randomly during January 2009 until January 
2011 at the Munich University Maternity Hospital, Munich, Germany. Samples were used for cell 
isolation and regulatory T cell (Treg) methylation analyses (Liu et al. 2010) and for studying cord 
blood T cell subsets upon retinoic acid (RA) stimulation (Lluis et al. Manuscript submitted).  
 
2.2.2 Blood collection and DNA extraction 
2.2.2.1 Cord blood samples  
Blood was collected in sodium heparin or EDTA containing tubes. Sodium heparin tubes were 
processed within the first 24h after blood collection with Ficoll-Paque™ PLUS (GE Healthcare, 
Piscataway, USA) and cord blood mononuclear cells (CBMCs) isolated for further experiments. 
EDTA tubes were frozen at -80°C within the first 24h upon blood withdrawal. Tubes were 
subsequently thawed and DNA was extracted with the FlexiGene DNA Kit following manufacturer’s 
instruction (Qiagen, Hilden, Germany).  
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2.2.2.2 The PASTURE/EFRAIM Study 
Processing of blood samples occurred within the first 24h upon withdrawal. Blood was kept in a 
serum-gel tube and sodium heparin tubes. The serum-gel tube was centrifuged, serum aliquoted and 
kept at -80°C for IgE measurements. Peripheral blood mononuclear cells (PBMCs) were isolated with 
Ficoll-Paque™ PLUS (GE Healthcare, Piscataway, USA) (Lluis, Depner et al. Manuscript submitted). 
 
2.2.3 IgE measurements 
For the PASTURE/EFRAIM study, specific immunoglobulin (Ig)E for six food and 13 common 
inhalant allergens was assessed at the age of 4.5 years in serum by the Allergy Screen test panel for 
atopy (Mediwiss Analytic, Moers, Germany) in a central laboratory. Food allergens included hen’s 
egg, cow’s milk, peanut, hazelnut, carrot, and wheat flour; inhalant allergens comprised D. 
pteronyssius, D. farinae, cat, horse, dog, Alternaria, mugwort, plantain, alder, birch pollen, hazel 
pollen, rye pollen, and a grass pollen mix. Sensitization against inhalant or food IgE was defined using 
RAST class 3 (≥3.5IU/mL) (Lluis, Depner et al. Manuscript submitted). 
 
2.2.4 Isolation and culture of mononuclear cells 
2.2.4.1 Birth cohort samples 
CBMCs from the PAULINA and the PAULCHEN study population were isolated within 24h after 
blood collection by density gradient centrifugation with Ficoll-Paque™ PLUS following 
manufacturer’s instructions (GE Healthcare, Piscataway, USA). Cells were washed with RPMI 1640 + 
GlutaMax (Gibco, Carlsbad, USA) and resuspended in medium 10% human serum (Sigma-Aldrich, 
Steinheim, Germany) at a final concentration of 5x10
6
cells/mL. Cells were stimulated with 
phytohemagglutinin (PHA, 5µg/mL), lipid A (LpA, 0.1µg/mL), peptidoglycan (Ppg, 10µg/mL) (all 
Sigma-Aldrich, Steinheim, Germany) and Dermatophagoides pteronyssinus 1 (Derp1, 30µg/mL) 
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(Indoor Biotechnologies, Charlottesville, USA) for 3 days and compared to unstimulated cells, which 
were processed immediately. Endotoxin concentrations in Ppg, Derp1 and PHA were measured by 
Limulus assay. Analyses indicated low levels of endotoxin (<0.01EU/m=0.002ng/mL) which did not 
significantly change cytokine secretion. After incubation at 37°C in a humidified 5% CO2 incubator 
cells were collected for flow cytometry analyses and/or mRNA extraction; and supernatants of 
CBMCs were frozen for cytokine measurements (Schaub et al. 2008; Schaub et al. 2009). 
 
2.2.4.2 The PASTURE/EFRAIM Study 
PBMCs from the PASTURE/EFRAIM study were isolated within 24h after blood collection by 
density gradient centrifugation with Ficoll-Paque™ PLUS (GE Healthcare, Piscataway, USA). Cells 
were washed with RPMI 1640 + GlutaMax (Gibco, Carlsbad, USA) and resuspended in medium 10% 
human serum (Sigma-Aldrich, Steinheim, Germany) at a final concentration of 5x10
6
cells/mL. Cells 
were incubated at 37°C in a humidified 5% CO2 incubator for 24h unstimulated or stimulated with 
PMA (5ng/mL) and Ionomycin (1µg/mL) (PI) or lipopolysaccharide (LPS, 0.1µg/mL) (Sigma-
Aldrich, Steinheim, Germany). After incubation cells were collected for flow cytometry analyses. 
 
2.2.5 Cytokine expression 
The concentration of cytokines in supernatants of CBMCs (PAULINA and PAULCHEN study) were 
measured with a Human Cytokine Multiplex Assay Kit, polystyrene bead-based, according to the 
manufacturer’s instructions using LUMINEX technology (Biorad, Hercules, USA). 
The lower limit of detection of the assay (pg/mL) was 1.1 (IL-2), 1.8 (IL-5), 0.5 (IL-6), 3.0 (TNF-), 
0.9 (IL-10), 2.1 (IL-13), 4.2 (IL-15), 0.2 (IL-17), 1.3 (IFN-), and 1.0 (GM-CSF) (Lluis et al. 2011) 
(Lluis et al. Manuscript submitted).  
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2.2.6 Flow cytometry analyses 
2.2.6.1 Birth cohort studies  
CBMCs from the PAULINA and the PAULCHEN study population were stained for surface markers 
of Treg cells (CD4, CD25) under stimulated (PHA, LpA, Ppg; incubated for 72h) (Sigma-Aldrich, 
Steinheim, Germany) and unstimulated (processed immediately) conditions. 
Cells were resuspended in RPMI 1640 + GlutaMax (Gibco, Carlsbad, USA) at 1x10
7
cells/mL. 25µL 
were incubated with 22µL FACS buffer, 2µL CD4-FITC a n d  1µL CD25-PC5 (Beckman Coulter, 
Fullerton, USA) antibodies for 30min at 4ºC. The corresponding isotype controls IgG1-FITC (Dako 
Cytomation, Glostrup, Denmark) and IgG2a-PC5 (Beckman Coulter, Fullerton, USA) were used for 
single staining. The samples were washed twice with 1mL FACS buffer and resuspended in 200µL 
FACS buffer + 200µL 1% PFA (Sigma-Aldrich, Steinheim, Germany) for flow cytometry acquisition. 
Data were acquired by FACScan with CellQuest Software (Beckton-Dickinson, Heidelberg, Germany) 
and post-acquisition analyses were performed with the WinMDI 2.8 software (The Scripps Research 
Institute, La Jolla, USA).  
 
2.2.6.2 The PASTURE/EFRAIM Study  
PBMCs from the PASTURE/EFRAIM study population (from samples recruited in Germany and 
France) were incubated for 24h unstimulated or PI- and LPS-stimulated (Sigma-Aldrich, Steinheim, 
Germany).  
Treg cells were stained using the CD4, CD25 and CD127 markers for a surface staining or by 
intracellular staining with the markers CD4, CD25 and FOXP3. Surface staining was assessed only for 
German samples and intracellular staining was performed for samples collected in Germany and 
France. 
Cells were resuspended in RPMI 1640 + GlutaMax (Gibco, Carlsbad, USA) at 1x10
7
cells/mL and 
different cell subsets were analyzed including activated T cells (CD4
+
CD25
+
) and Treg cells ( defined 
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as CD4
+
CD25
high
CD127
low/-
 and CD4
+
CD25
high
FOXP3
+
 in addition to CD4
+
CD25
+
CD127
low/-
 and 
CD4
+
CD25
+
FOXP3
+
). 
For surface staining, 2.5x10
5 
cells were stained with 2µL CD4-FITC, 1µL CD25-PC5 (Beckman 
Coulter, Fullerton, USA) and 2µL CD127-PE (eBioscience, San Diego, USA) antibodies. The 
corresponding isotype controls IgG1-FITC, IgG1-PE (Dako Cytomation, Glostrup, Denmark)) and 
IgG2a-PC5 (Beckman Coulter, Fullerton, USA) were used. 
For intracellular FOXP3 staining the Human Regulatory T Cell Staining Kit (eBioscience, San Diego, 
USA) or Human FoxP3 Buffer Set (BD Pharmingen, Franklin Lakes, USA) was used. 10
6 
cells were 
stained with 8µL CD4-FITC, 4µL CD25-PC5 antibodies (Beckman Coulter, Fullerton, USA) and 
10µL FOXP3-PE (eBioscience, San Diego, USA) in Germany or 3µL CD4-FITC, 3µL CD25-APC 
and 3µL FOXP3-PE (BD Pharmingen, Franklin Lakes, USA) in France. Corresponding FOXP3 
isotype antibodies IgG2a-PE (eBioscience, San Diego, USA) or IgG1-PE (BD Pharmingen, Franklin 
Lakes, USA) were used as controls, respectively. Acquisition was performed with CellQuest or 
CellQuest Pro Software for FACScan and FACSCalibur (Becton-Dickinson, Heidelberg, Germany) 
and with FACS Diva software for FACS Canto II (Becton-Dickinson, Heidelberg, Germany). 
Analyses were performed with FCS express v3 (De Novo Software, Los Angeles, USA) and FACS 
Diva software (Becton-Dickinson, Heidelberg, Germany).  
To objectively quantify Treg cells, CD4
+
CD25
high
 cells were defined as the upper 20% of CD4
+
CD25
+
 
(Upper20%CD4
+
CD25
+
). In Germany, a subjective gate defined by the investigator, named 
CD4
+
CD25
high
, was used for surface staining analyses. CD127
low/-
 included the population where 
CD127 was lowly expressed and the negative CD127 population. 
 
2.2.7 Isolation and suppressive function of regulatory T cells 
To assess the suppressive function of regulatory T (Treg) cells, the division and the proliferation of 
effector T cells (Teff) were analyzed (Liu et al. 2010). 
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Antigen presenting cells (APCs) were isolated after positive depletion of CD3
+
 cells with CD3 
MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and irradiated (30 Gy, 3000 rad, 10min). 
CD4
+
CD25
−
 effector T cells and CD4
+
CD25
+ 
T cells were isolated (in a two-step-procedure) using 
depletion of non-CD4
+
cells followed by positive selection (run twice) of CD4
+
CD25
+ 
T cells with the 
CD4
+
CD25
+ 
Regulatory T Cell Isolation Kit (Miltenyi Biotec, Bergisch Gladbach, Germany). For the 
analyses of cell division, CD4
+
CD25
−
 T cells (2×10
4
/well) labelled with 5µM CFSE 
(carboxyfluorescein diacetate succinimidyl ester) (Invitrogen, Carlsbad, USA) were incubated for 3 
days with irradiated CD3
-
 cells (4×10
4
/well) in co-culture with/without CD4
+
CD25
+ 
T cells 
(2×10
4
/well) with 0.8µg/mL PHA stimulation (Sigma-Aldrich, Steinheim, Germany). Division was 
assessed by flow cytometry.  
For proliferation analyses of effector cells CD4
+
CD25
−
 T cells (2×10
4
/well) were incubated for 3 days 
with irradiated CD3
-
 cells (4×10
4
/well) in co-culture with/without CD4
+
CD25
+ 
T cells (2×10
4
/well) 
with 0.8µg/mL PHA stimulation (Sigma-Aldrich, Steinheim, Germany). Upon 72h, 25µL tritium 
methyl-H3-thymidin (1uCi/well) (Amersham, Piscataway, USA) was added. After additional 8h 
incubated 3-[H]-thymidin incorporation was assessed. The suppressive capacity of Treg cells was 
defined as the following: 
Tregswithoutcells Teffofprolif.or division
Tregswithcells Teffofprolif.ordivisionTregswithoutcells Teffofprolif.or division )()( 
 
 
2.2.8 FACS sorting of regulatory T cells and T effector cells 
FACS sorting was performed to determine FOXP3 demethylation at the Treg-specific demethylated 
region (TSDR), a marker for Treg cells, in isolated CD4
+
CD25
high
 cells, namely Treg cells; and in 
CD4
+
CD25
-
 cells of CBMCs (Liu et al. 2010). 
Upon isolation of CBMCs using Ficoll-Paque™ PLUS (GE Healthcare, Piscataway, USA) within the 
first 24h after blood collection, cells were stained with the surface markers anti-human CD4-FITC 
(40µL) and CD25-PC5 (20µL) (Beckman Coulter, Fullerton, USA) per 1×10
7
 cells and sorted by 
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FACS MoFlo XDP (Beckman Coulter, Fullerton, USA) in two subpopulations: CD4
+
CD25
−
 and 
CD4
+
CD25
high
 cells. DNA extraction was performed with QIAamp DNA Micro-Kit following 
manufacturer’s instructions (Qiagen, Hilden, Germany) and FOXP3-methylation specific real-time 
PCR as described in section 2.2.9. 
 
2.2.9 FOXP3 methylation analyses 
FOXP3 methylation analysis was performed in the Treg-specific demethylated region (TSDR) of 
FOXP3 locus in cord blood EDTA and in isolated T cell subsets (Liu et al. 2010). 
Genomic DNA was isolated from EDTA-handled cord blood with FlexiGene DNA Kit following 
manufacturer’s instructions (Qiagen, Hilden, USA). From 2mL EDTA-blood, a recovery of 300–
900µg/µL DNA was sufficient for the 20ng of DNA required for methylation analyses. In case of 
FACS sorted samples, DNA was isolated with QIAamp DNA Micro-Kit (Qiagen, Hilden, USA) (see 
section 2.2.8). For measurement of the FOXP3 TSDR real-time-PCR was performed by a collaborator 
(Epiontis GmbH, Berlin, Germany) in 20µL using Roche LightCycler 480 Probes Master (Roche 
Diagnostics, Mannheim, Germany) containing 15pmol of methylation or non-methylation-specific 
forward and reverse primers for TSDR, 5pmol hydrolysis probe, 200ng lambda-DNA and 30ng 
bisulfite-treated genomic DNA template or respective amount of plasmid standard (Baron et al. 2007). 
Each sample was analyzed in triplicate using a Light-Cycler 480 system (Roche Diagnostics, 
Mannheim, Germany). Of note, FOXP3 is a X-linked gene. In females, having two X-chromosomes, 
Treg cell X-inactivation leads to complete inactivation and methylation of the bar body and one out of 
the two X-chromosomes in Treg cells of female subjects remains fully methylated. The other “open” 
X-chromosome is demethylated in female Treg cells. This does not apply to male subjects as they 
carry only one X chromosome which is therefore demethylated. For calculation of Treg ratios in a 
given cell sample, it is necessary to multiply with a factor of 2 in all samples of female subjects in 
order to determine the Treg number (Liu et al. 2010).  
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2.2.10 Real-time RT-PCR 
Total RNA, isolated with TRIzol Reagent (Invitrogen, Carlsbad, USA) and reverse transcription of 
1μg RNA with QuantiTect Rev. Transcription Kit were performed according to the manufacturers´ 
instructions (Qiagen, Hilden, Germany). mRNA-specific oligonucleotide primers (Forward/Reverse) 
of housekeeping gene 18S rRNA, the Treg specific transcription factor FOXP3, and Th17-lineage 
related markers RORC (isoform b, primers “RORC3” and isoforms a+b, primers “RORC4”), RORA, 
IL-17, IL-17F, IL-22 and IL-23R  and the genes located within the asthma-associated 17q21 region 
ORMDL3, GSDMA, GSDMB, ZNFN1A3, ZPBP2 and PSMD3 were designed with Vector NTI 
Advance10 (Invitrogen) (Table I). Direct detection of the PCR product with iCycler iQ™ Real Time 
PCR (Biorad, Hercules, USA) was monitored by measuring the increase in fluorescence caused by 
binding of SYBR Green (Applied Biosystems, Foster City, USA) to double-stranded DNA. The 
determined cycle threshold (CT) was set in relation to the amplification plot of 18S rRNA. The CT is 
the number of PCR cycles required for the fluorescence signal to exceed the detection threshold value, 
which was set to the log-linear range of the amplification curve. For the calculation of delta CT (Δct), 
the difference in CT values of two genes was used. A higher Δct resembles lower mRNA expression 
(Gibson et al. 1996; Liu et al. 2010; Lluis et al. 2011) (Lluis et al. Manuscript submitted).  
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Table II. Primer sequences (Forward and Reverse). 
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2.2.11 Retinoic acid stimulation in cord blood mononuclear cells 
Th17 and Treg cells were analyzed in CBMCs upon stimulation with retinoic acid (RA), a known 
modulator of Treg/Th17 regulation in mice and adults (Mucida et al. 2007; Bai et al. 2009). 
Both unstimulated or PHA stimulated (5ug/mL) CBMCs were incubated with or without RA. Three 
different doses of retinoic acid were used: 2.5nM, 50nM, 100nM. Cells were harvested after 48h for 
gene expression analyses of FOXP3, RORC and IL-23R. (Lluis et al. Manuscript submitted). 
 
2.2.12 Single nucleotide polymorphisms selection and genotyping 
Genotype data for seven single nucleotide polymorphisms (SNPs) within the Th17-lineage genes 
RORC, IL-23R and IL-17 including approximately 5kb boarders up- and downstream of each genetic 
region was extracted from the MAGICS/ISAAC discovery dataset (Moffatt et al. 2007) using the 
PLINK software package version 1.07 (Purcell et al. 2007). SNPs associated with asthma in the 
MAGICS/ISAAC discovery dataset were identified (Moffatt et al. 2007) and genotyped in the 
PAULCHEN study population for functional assessment.  Additionally, rs2275913 was included in 
this study due to its potential functional relevance in IL-17 regulation and asthma (Chen et al. 2010; 
Espinoza et al. 2011) (Lluis et al. Manuscript submitted). Furthermore, 10 SNPs covering the 17q21 
locus were selected based on the previous GWAS where these 17q21 polymorphisms were associated 
with the development of asthma in 2 independent study population of children (Moffatt et al. 2007) 
and genotyped in the PAULCHEN and PAULINA study. Genotyping was performed by Matrix-
assisted laser desorption/ionization time-of-flight mass spectrometry (Ding et al. 2003; Schedel et al. 
2004) at the Institute of Epidemiology (Helmholtz Centre Munich, Neuherberg, Germany). The 
genotyping success-rate was at least 94%, whereas rs2290400 in 17q21 region was excluded from all 
analyses because genotyping was not successful. None of the polymorphisms significantly deviated 
from Hardy-Weinberg equilibrium (HWE) with the level of significance set to p≤0.05 (Lluis et al. 
2011). 
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2.2.13 Statistical analyses  
Data analyses were performed with SigmaStat 1.0 and SAS 9.2 software as depicted below in detail.  
 
2.2.13.1 FOXP3 methylation analyses 
Correlations of FOXP3 demethylation with other Treg markers including FOXP3 gene expression and 
CD4
+
CD25
high
 T cells were analyzed using Pearson Product Moment Correlation or Spearman Rank 
Order Correlation based on distribution of the data. The comparison of the suppressive capacity of 
Treg cells (%) in the samples below and above the median of FOXP3 demethylation (%) was analyzed 
with T-test. Statistical significance was defined by p≤0.05. Analyses were performed with Sigmastat 
version 1.0. 
 
2.2.13.2 Regulatory T cells in 4.5 year-old farming children (the PASTURE/EFRAIM 
Study) 
Percentages of specific cells relative to the lymphocyte population were used as Treg cell markers. As 
the distribution of Treg cells (%) was partly not normally distributed, all markers for Treg cells were 
log10-transformed, and 0 values in the percentages were set to a minimal value of 0.005 before log-
transformation.  
Data analyses for Treg cell markers on the surface were performed only in the German subgroup while 
intracellular analyses were performed in both, German and French children. Intracellular data were 
also analyzed stratified by center. 
Association between Treg markers and farm-related variables were analyzed by regression analyses of 
the log-transformed variables. Geometric mean ratios and 95%-confidence intervals (CI) are reported. 
Additionally, non-parametric Wilcoxon or Kruskal-Wallis tests were used (to confirm the results).  
Associations between atopic sensitization and Treg markers were analyzed by logistic regression. 
Odds Ratios and 95%-CI are given on the log 10-scale. All analyses for intracellular staining were 
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adjusted for center. Additional relevant covariates included in some of the models are mentioned in the 
respective results section. 
Statistical significance was defined by p≤0.05, and all analyses were performed using SAS 9.2. 
 
2.2.13.3 Th17 cells in cord blood of a farming population (the PAULCHEN Study) 
Gene expression of Th17-lineage related markers were analyzed in cord blood samples of a farming 
population. Non-detectable samples were set to 38 CT to be included in the analyses. In the statistical 
analysis (Ballenberger et al. Manuscript submitted) these values were considered to be right censored 
as being “>38”. The data were not normally distributed and could not be transformed to normality. 
Hence, non-parametric tests and models were applied. Summary statistics such as the median and its 
confidence interval was conducted by the Kaplan-Meier method (Kaplan et al. 1958), which is a non-
parametric procedure taking right censoring at multiple detection levels into account.  
Testing on group differences without adjusting for covariates was performed by the generalized 
Wilcoxon test (Prentice 1978), which tests whether the survival functions of two or more groups 
statistically differ. Its application to environmental settings with censored data is recommended by 
NADA (Helsel 2005). In order to adjust for covariates the Tobit model (Tobin 1958) was applied to 
the ranks of the original data. Rank transforming was conducted as the assumption of normality was 
violated. According to Iman and Conover (Iman et al. 1979) regression on rank transformed data is a 
distribution free procedure. Tobit regression (on ranks) takes both left and right censoring with 
multiple detection levels into account.  
Additionally, an interaction term was added to the model which was defined as the product of a 
dichotomous and a continuous variable, meaning that the influence of one variable on the other is 
dependent of the level of a third variable. An interaction effect with p≤0.05 was considered to be 
significant.  
Statistical analysis was performed with SAS 9.2. Statistical significance was defined by p≤0.05. 
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2.2.13.4 Retinoic acid stimulation experiments 
Gene expression of Treg and Th17 markers was analyzed in cord blood before and upon stimulation 
with retinoic acid (RA) at different doses. Non-detectable samples were set to 38 CT to be included in 
the analyses.  
Summary statistics such as the median and quartiles was conducted by the Kaplan-Meier method 
(Kaplan et al. 1958). For the comparison of paired censored observations the paired Prentice- 
Wilcoxon test was performed (O'Brien et al. 1987). A p-value ≤0.05 was considered to be significant. 
Statistical analysis was performed with SAS 9.2. 
 
2.2.13.5 Single nucleotide polymorphisms in Th17-lineage genes 
For Th17-lineage SNPs, Th17 and Treg cell markers were analyzed on a protein and mRNA level. Th1 
and Th2 cytokines were assessed at protein level. 
For PCR analysis, non-detectable samples were set to 38 CT and after cytokine measurements, non-
detectable concentrations were set to 0.01pg/mL to be included in the analyses. In the statistical 
analyses (Ballenberger et al. Manuscript submitted) these values were considered to be right and left 
censored as being “>38” and “<0.01” respectively. 
Summary statistics such as the median and quartiles was conducted by the Kaplan-Meier method 
(Kaplan et al. 1958). 
Testing on group differences was performed by the generalized Wilcoxon test (Prentice 1978) using 
SAS 9.2. Statistical significance was assigned to values p≤0.05.  
A recessive model (recessive on the rare allele) was used comparing carriers of the rare allele in 
comparison to the two other putative allelic states together. A dominant model was applied to compare 
the homozygous wildtype (WT) carriers vs. the heterozygous and homozygous SNP carriers. The 
models increased the statistical power and avoided the heterozygous effect observed in the linear 
model (Lluis et al. Manuscript submitted).   
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2.2.13.6 Single nucleotide polymorphisms in 17q21 region 
As described in Lluis et al. (Lluis et al. 2011), all SNPs were tested for deviation from Hardy-
Weinberg equilibrium by χ
2
 test. Linkage disequilibrium (LD) between all SNPs was calculated by 
using R
2
. The R
2
 threshold was set to 0.85 to determine tagging SNPs, each representing one tagging 
bin. Bins correspond to LD blocks. LD patterns in our population were highly comparable to the data 
reported for the HapMap CEU (Utah residents with Northern and Western European ancestry from the 
Centre d'Etude du Polymorphisme Humain collection) population (http://hapmap.ncbi.nlm.nih.gov). 
For the combination of tagging SNPs, haplotype frequencies were estimated by using the expectation-
maximization algorithm. Because allele frequencies for most of the 17q21 SNPs were close to 50%, 
the respective risk allele (instead of the minor allele) was reported. The risk allele was defined as the 
allele increasing the risk for the development of childhood asthma as described in the GWAS 
publication (Moffatt et al. 2007).  
Risk and non-risk haplotypes were defined. The non-risk haplotype  contains non-risk alleles only of 
the 4 tagging SNPs, whereas the risk haplotype contains of all respective risk alleles. An allele-
counting model was assumed for the genotypes (0, homozygous non-risk; 1, heterozygous; 2, 
homozygous risk). 
For RT-PCR analysis, the Wilcoxon test was used for the comparison of ΔCT values because some 
ΔCT values were not normally distributed. A Bonferroni-based correction was used to adjust for 
multiple testing. As we tested gene expression in relation to 4 tagging SNPs after no stimulation and 
innate and adaptive stimulation (N=3), we used a significance threshold of 0.05/12=0.004 for SNP 
analyses. Data below the multiple testing significance threshold of p≤0.004 were marked (*) in all 
figures. 
Multiple regression analysis and Kruskal-Wallis tests were performed to test for differences of 
cytokine concentrations for different genotypes. Non-detectable concentrations were set to 0.01 pg/mL 
to include the subjects in the analysis. Because the distribution of cytokine levels was skewed, 
variables were log-transformed, and geometric mean ratios (GMRs) and 95% CIs were computed. 
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Validating the results by methods that take censoring into account (generalized Wilcoxon test and 
Tobit model) resulted in comparable data. All GMRs were reported in an unadjusted model (crude) or 
in an adjusted model for maternal atopy. Statistical significance was defined by p≤0.05. 
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3 Results 
3.1 The role of regulatory T cells during immune maturation 
Regulatory T (Treg) cells are a population of the immune system capable to suppress the immune 
responses of other cells and to maintain tolerance to self antigens. In the last years they have been 
related to the pathogenesis of atopic diseases (ADs). However their role during immune maturation in 
the development of ADs in childhood remains unclear. 
In this study, Treg cells were examined during early immune maturation at different levels. First, the 
reliability of a good quantitative marker for Treg cells in adults, FOXP3 demethylation at Treg-
specific demethylated region (TSDR), was assessed in cord blood. Second, Treg cells were analyzed 
in 4.5 year-old children in relation to farming exposure and their contribution in the allergy-protective 
effect observed in farming children. 
 
3.1.1 FOXP3 demethylation in cord blood as a reliable quantitative marker of 
regulatory T cells 
The transcription factor FOXP3 is the most specific marker used to quantify Treg cells to date. FOXP3 
demethylation at the TSDR has been suggested as a novel and specific marker for natural Treg (nTreg) 
cells in adults (Baron et al. 2007). However, little is known about TSDR demethylation in nTreg cells 
early in life. Thus, a comparison between FOXP3 demethylation to previously described Treg markers 
such as CD4
+
CD25
high
, FOXP3 mRNA levels and Treg suppressive capacity was analyzed in cord 
blood mononuclear cells (CBMCs) (Liu et al. 2010). 
CBMCs from 70 healthy neonates were isolated. Cells were either unstimulated or stimulated for 3 
days with the microbial stimulus Lipid A (LpA). Treg cells were quantified by flow cytometry 
(CD4
+
CD25
high
), mRNA expression (FOXP3) and suppressive Treg function was analyzed. FOXP3 
demethylation at TSDR was investigated in whole EDTA-blood. Cord blood CD4
+
CD25
-
 and 
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CD4
+
CD25
high
 cells were sorted by FACS and FOXP3 protein expression or demethylation at TSDR 
was assessed (Liu et al. 2010).  
 
3.1.1.1 FOXP3 demethylation was specific for isolated regulatory T cells in cord blood 
To confirm the specificity of FOXP3 demethylation in cord blood Treg cells, unstimulated 
CD4
+
CD25
-
 and CD4
+
CD25
high
 cells were FACS-sorted and FOXP3 demethylation at the TSDR was 
analyzed. FOXP3 demethylation was hardly detectable in CD4
+
CD25
−
 cells (<1%) while FOXP3 was 
81% demethylated in CD4
+
CD25
high 
T cells (Figure 2 A/B). FOXP3 expression was also measured by 
flow cytometry in the CD4
+
CD25
high
 population, being expressed with a mean of 90%; one 
representative sample is depicted in Figure 2 C (Liu et al. 2010). 
 
 
 
Figure 2. FOXP3 demethylation in isolated CD4
+
CD25
- 
and CD4
+
CD25
high
 cells. A/B. CD4
+
CD25
- 
 
and CD4
+
CD25
high
 cells were isolated with Dako MoFlow. DNA was extracted and demethylation (%) 
of FOXP3 was measured by real-time PCR. C. Intracellular FOXP3 protein was measured in 
CD4
+
CD25
high
 cells as described in methods. N=5, mean±SEM were shown in B, one representative 
sample for A/C. 
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3.1.1.2 Demethylation of FOXP3 correlated with FOXP3 gene expression in cord blood 
Gene expression of FOXP3 was determined in unstimulated and stimulated cord blood samples and 
correlated to FOXP3 demethylation in whole cord blood. Figure 3 shows FOXP3 mRNA expression 
as Δct values, axis vice versa. A lower Δct resembles higher FOXP3 gene expression. FOXP3 mRNA 
expression in unstimulated (U) and LpA stimulated cells was positively correlated with demethylation 
(%) of FOXP3 in whole blood, though with low correlation coefficient (r=0.32, p=0.02; r=0.29, 
p=0.05, respectively; Figure 3 A/B) (Liu et al. 2010).  
 
 
Figure 3. Correlation between demethylation of FOXP3 and unstimulated and LpA-stimulated 
FOXP3 mRNA expression. Demethylation (%) of FOXP3 in whole cord blood was measured by real-
time PCR. FOXP3 gene expression was measured by real-time RT-PCR in A. unstimulated and B. 
LpA-stimulated CBMCs, shown as Δct to 18SrRNA. Lower Δct represents higher mRNA expression. 
N=48; correlation was analyzed with Pearson’s correlation coefficient. 
 
3.1.1.3 Demethylation of FOXP3 correlated with CD4+CD25high T cells in cord blood 
Treg cells express high amounts of the IL-2 receptor (CD25). CD4
+
CD25
high
 is a common marker used 
to define Treg cells by flow cytometry. FOXP3 demethylation in whole blood (%) was positively 
correlated with the amount of unstimulated and LpA-stimulated CD4
+
CD25
high
 T cells in cord blood 
(r=0.49, p<0.05) (Figure 4 A/B) (Liu et al. 2010). 
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Figure 4. Correlation between demethylation of FOXP3 and CD4
+
CD25
high
 T cells (%). 
Demethylation (%) of FOXP3 was measured by real-time PCR. CD4
+
CD25
high
 T cells (% in 
lymphocytes) were measured by flow cytometry. A. Correlation between FOXP3 demethylation and 
unstimulated CD4
+
CD25
high
 T cells (%, N=20). B. Correlation between FOXP3 demethylation and 
LpA-stimulated CD4
+
CD25
high
 T cells (%, N=24); correlation was analyzed with Pearson’s correlation 
coefficient. 
 
3.1.1.4 Demethylation of FOXP3 correlated with the suppressive capacity of regulatory T 
cells in cord blood 
As the quantification of Treg cells is not indicative of Treg function, the suppressive capacity of 
CD4
+
CD25
high
 T cells on the division and proliferation of CD4
+
CD25
−
 T effector cells was 
additionally assessed in a subgroup of cord blood samples (N=13). Cell division was measured with 
CFSE (carboxyfluorescein diacetate succinimidyl ester) labeling of effector cells. In addition, 
proliferation was measured by 3 [H]-thymidin incorporation reflecting the overall capacity of effector 
cell proliferation.  
The suppressive capacity of Treg cells on cell division was positively correlated with demethylation of 
FOXP3 (r=0.72, p=0.005, Figure 5 A), while the suppressive capacity of Treg cells on proliferation 
showed a trend correlated with demethylation (r=0.4, p=0.2, Figure 5 B). When dividing FOXP3 
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demethylation according to the median (0.70%) into groups with relatively higher or lower 
demethylation, the suppressive capacity of Treg cells on effector cells (division and proliferation) was 
significantly more effective in the group with higher compared to the lower demethylation (p=0.005, 
p=0.03; Figure 5 C) (Liu et al. 2010). 
 
 
 
Figure 5. Relationship between demethylation (%) of FOXP3 and suppressive capacity of Treg cells. 
Demethylation (%) of FOXP3 was measured by real-time PCR. A. Correlation of demethylation of 
FOXP3 and suppressive capacity of CD4
+
CD25
high
 T cells on the division of CFSE-labelled 
CD4
+
CD25
−
 T effector cells assessed by flow cytometry. B. Correlation of demethylation of FOXP3 
and suppressive capacity of CD4
+
CD25
high
 T cells on the proliferation of CD4
+
CD25
−
 T effector cells, 
measured with 3[H]-thymidin incorporation. C. The suppressive capacity of Treg cells was more 
effective in cord blood with higher FOXP3 demethylation (%) (>median of 0.70). A–B: N=13/12; 
Pearson’s correlation coefficient. C: N=13, t-test, data were shown as mean±SEM. 
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3.1.2 Regulatory T cells in a farming population in early childhood (the 
PASTURE/EFRAIM Study) 
In the PAULCHEN birth cohort study higher Treg cell numbers and more efficient Treg cell function 
were observed in cord blood from farm exposed mothers (Schaub et al. 2009). Along with these 
findings FOXP3 demethylation was increased in offspring of mothers with farm milk exposure 
(Schaub et al. 2009). Indeed, several cross-sectional studies demonstrated that farm exposure is a 
protective factor against the development of atopic diseases (ADs) in childhood (Riedler et al. 2001; 
Braun-Fahrlander et al. 2002; Ege et al. 2006), a phenomenon known as the “farm effect”. In this 
context it was shown that early life exposure is relevant, which suggest an influence on immune 
maturation (Ege et al. 2006). However, little is known whether these previously reported differences 
observed in Treg cells in cord blood from farming children persist over time in childhood and whether 
they may be relevant for the development of atopic diseases in childhood. To investigate this 
hypothesis, Treg cells were studied in children at age 4.5 years in the context of farming exposure and 
their role in the allergy-protective “farm effect” was determined. 
For this purpose 325 German or French children from the PASTURE/EFRAIM study (von Mutius et 
al. 2006) were followed until the age of 4.5 years. Treg cells were analyzed in PBMCs from these 
subjects in unstimulated (U) and stimulated (PI=PMA/Ionomycin, LPS=Lipopolysaccharide) 
conditions (Lluis, Depner et al. Manuscript submitted).  
Population characteristics are shown in Table I and are described in detail in Material and Methods 
section 2.2.1.1.3. 
 
3.1.2.1 Regulatory T cells in 4.5 year-old children  
Treg cells relative to the lymphocyte population (in %) were assessed by measuring the expression of 
CD4
+
CD25
high
 in combination with low surface expression of CD127 or with intracellular expression 
of FOXP3 before and following stimulation with PI and LPS. The distribution of the respective cells 
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(%) and the medians are shown in Figure 6. The median of typical Treg cell markers 
CD4
+
25
high
FOXP3
+
, defined here as Upper20%CD4
+
CD25
+
, FOXP3
+
;
 
and CD4
+
25
high
CD127
low/-
 under 
unstimulated conditions was 0.2 % (Figure 6 A/B). These results indicate that the percentage of Treg 
cells in 4.5 year-old children was generally low. 
After LPS stimulation a slight increase in Treg cells was observed (median of Upper20%CD4
+
CD25
+
, 
FOXP3
+
,
 
CD4
+
25
high
CD127
low/-
; 0.3%, 0.2%, respectively Figure 6 A/B). PI stimulation increased the 
activated T cell populations and to a lower extent the Treg cell population (median 
Upper20%CD4
+
CD25
+
, FOXP3
+
,
 
CD4
+
25
high
CD127
low/-
; 0.4%, 0.9%, respectively) (Lluis, Depner et 
al. Manuscript submitted).  
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Figure 6. Distribution of activated T cells and Treg cells relative to lymphocytes (%). A. By surface 
staining using the markers CD4, CD25, CD127 (N=157, Germany) B. By intracellular staining using 
the markers CD4, CD25, FOXP3 (N=298, Germany and France). 
 
 
3.1.2.2 Regulatory T cells were quantitatively increased in blood from farming children 
Next, it was investigated whether Treg cells (%) were consistently increased in 4.5 year old children 
exposed to a farming environment compared to non-farming children living in the same rural area 
(Table III). This effect was significant for Treg cells determined by intracellular staining 
(Upper20%CD4
+
CD25
+
, FOXP3
+
)  upon stimulation (PI and LPS), being more pronounced upon LPS 
stimulation (GMR and 95%-C.I. for Upper20%CD4
+
CD25
+
, FOXP3
+
, PI, LPS; 1.23 [1.04 - 1.46]; 
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p=0.01; 1.44 [1.15 - 1.79]; p=0.001, respectively) (Lluis, Depner et al. Manuscript submitted). 
Moreover, activated CD4
+
CD25
+
 T cells were also significantly increased upon stimulated conditions 
(PI, LPS) in the intracellular staining (Table III). Interestingly, Treg cells (%) (surface staining 
CD4
+
CD25
high
CD127
low/-
) in the German farming population were also increased in unstimulated 
samples (GMR and 95%-C.I. 1.31 [1.04 - 1.66]; p=0.02). 
Table III. Association of activated T cells and Treg cells with farming lifestyle. 
 
1 
Intracellular staining adjusted for center. 
2 
U, unstimulated; PI, PMA/Ionomycin; LPS, Lipopolysaccharide. 
3 
GMR= geometric mean ratio, 95%.-C.I. =95%-confidence intervals, p=p-value of regression analyses in the 
log-transformed data. 
P values in bold letters reached significance with p≤0.05. 
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3.1.2.3 Farm milk consumption was associated with increased regulatory T cells in early 
childhood 
To further dissect specific farm-related factors potentially influencing Treg cell expression, we studied 
the effect of several farm exposures (being in stables, farm milk consumption, regular contact to hay, 
type of farm and number of animal species) on Treg cells.  
Both farm milk consumption and staying in stables were associated with increased Treg cells (%) 
upon PI and LPS stimulation, but only current farm milk consumption remained significant upon 
adjustment for farming (Table IV, GMR and 95%-C.I for Upper20%CD4
+
CD25
+
, FOXP3
+
; 1.36 [1.08 
- 1.70]; p=0.008; 1.46 [1.10 - 1.94]; p=0.01, respectively). Additionally, an increase in Treg cells 
(CD4
+
25
high
CD127
low/-
) measured by surface staining was seen upon PI and LPS stimulation (p<0.05). 
All other farm-related exposures analyzed including regular contact to hay, type of farm and number 
of exposed animal species at age 4 did not show any association (Table IV) (Lluis, Depner et al. 
Manuscript submitted).  
The influence of farm milk consumption on Treg cells was further investigated in the subgroups of 
farm and reference children. Although there was an overlap between farming and farm exposures, 
some farm children did not consume farm milk while some reference children drank farm milk (Figure 
7).  
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Figure 7. Farm milk consumption in farm and reference children 
 
 
 
A consistent positive association between Treg cells and farm milk consumption was observed after PI 
and LPS stimulation in farm and reference children, reaching significance only within the reference 
group, particularly without contact to stable (Table V) (Lluis, Depner et al. Manuscript submitted).  
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In a next step, specific patterns of farm milk consumption (exclusively drinking farm milk or a mixed 
consumption of farm and shop milk) were analyzed. Children only drinking shop milk were defined as 
the reference group. These data indicated that the observed effect on Treg cells was independent of the 
pattern of farm milk consumption (Table VI, A). Consumption of boiled and unboiled farm milk also 
revealed a similar effect on Treg cells (Table VI, B) (Lluis, Depner et al. Manuscript submitted). 
 
 
 
Table VI. Association of activated T cells and Treg cells with specific milk consumption. A. Farm 
and shop milk consumption vs. exclusively farm milk consumption. B. Boiled vs. unboiled farm milk 
consumption. 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. 
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1
 Reference group are 135 children who only drink shop milk; analyses for intracellular staining adjusted for 
center.  
2 
U, unstimulated; PI, PMA/Ionomycin; LPS, Lipopolysaccharide. 
3 
GMR= geometric mean ratio, 95%.-C.I. =95%-confidence intervals, p=p-value of regression analyses in the 
log-transformed data. P values in bold letters reached significance with p≤0.05. 
 
 
To assess whether farm milk consumption earlier in life may already lead to increased Treg cells at 
age 4.5 years, the role of farm milk consumption at different time points was studied.  
Because consumption at different time points was highly correlated, a categorical variable (combining 
farm milk consumption in pregnancy and childhood) was analyzed. In this study population 18.2% of 
children drank farm milk although the mother did not consume any farm milk during pregnancy. It 
was observed that only very few children (3.4%) were not exposed to farm milk consumption in their 
childhood when mothers drank farm milk during pregnancy. In each group under study consuming 
farm milk led to increased Treg cells (%). This effect was more pronounced in children exposed to 
farm milk already prenatally and in childhood (Table VII) (Lluis, Depner et al. Manuscript submitted). 
Due to low numbers it was not possible to disentangle this effect during pregnancy only (Table VII).  
 
B. 
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3.1.2.4 Regulatory T cells were inversely associated with atopic sensitization at age 4 years 
It has been demonstrated that farming lifestyle is a protective factor for the development of atopic 
diseases in childhood. In this study, Treg cells were increased (%) in 4.5-year-old farming children 
and in children drinking farm milk. Thus, as a next step it was investigated whether Treg cells were 
inversely associated with atopic sensitization at age 4 years. 
Treg cells (Upper20%CD4
+
CD25
+
, FOXP3
+
) were negatively associated with food and inhalant 
allergens. Unstimulated Treg cells were significantly associated with lower sensitization to inhalant 
allergens (≥3.5IU/mL) (Upper20%CD4
+
CD25
+
, FOXP3
+
, adjusted odds ratio (OR=0.38 [0.16-0.86]; 
p=0.02) (Table XVIII) (Lluis, Depner et al. Manuscript submitted). 
Table VIII. Association of Treg cells and atopic sensitization (IgE ≥3.5IU/mL). 
 
1
 All analyses are adjusted for farming, analyses for intracellular staining additionally adjusted for center. 
2 
U, unstimulated; PI, PMA/Ionomycin; LPS, Lipopolysaccharide. 
3 
OR= Odds ratio, 95%.-C.I. =95%-confidence intervals, p=p-value of logistic regression analyses in the log-
transformed data. P values in bold letters reached significance with p≤0.05. 
3. RESULTS 
 
- 55 - 
In summary, FOXP3 demethylation was a reliable marker to assess Treg cells in cord blood. Besides, 
Treg cells were increased (%) in a farming population at age 4.5 years. In addition, farm milk 
consumption in early childhood led to an increase of Treg cells (%) and an inverse association of Treg 
cells with inhalant IgE was observed at age 4 years. These data suggests a potential protective 
influence for the development of atopic diseases in childhood.  
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3.2 The role of Th17 cells during immune maturation 
3.2.1 The relevance of Th17 cells in cord blood 
Early life contact and particularly prenatal exposure to a farm environment is a protective factor for 
the development of ADs, potentially through an effect on immune maturation (Ege et al. 2006; von 
Mutius et al. 2010). Previous studies suggest that Treg and Th17 cells are involved in the 
inflammatory process and/or immunopathogenesis of ADs (Bullens et al. 2006; Koga et al. 2008; 
Ryanna et al. 2009; Strickland et al. 2011). Indeed, Treg cells were increased and functionally more 
suppressive in cord blood from neonates born in a faming environment compared to reference 
neonates from the same rural areas (Schaub et al. 2009). However, little is known whether Th17 cells, 
a cell subset generally increased in ADs (Bullens et al. 2006; Koga et al. 2008), may be altered in 
children growing up on a farm. To date, analyses of IL-17 expression in cord blood of farming 
compared to non-farming mothers did not reveal any significant difference (Schaub et al. 2009). 
However, more analyses are required to address this complex question in more detail. 
Hence, gene and protein expression of Th17-lineage related markers including the transcription factors 
RORC and RORA, the cytokines IL-17, IL-17F and IL-22 and the transmembrane protein IL-23R were 
analyzed unstimulated and after innate (Lipid A, LpA; peptidoglycan, Ppg) and mitogen 
(phytohemagglutinin, PHA) stimulation in neonatal cord blood from 22 farming and 60 non-farming 
mothers (Lluis et al. Manuscript submitted). 
 
3.2.1.1 Th17-lineage markers were expressed in cord blood 
Gene expression of Th17-lineage markers was assessed in unstimulated and stimulated (PHA; LpA; 
Ppg) cord blood samples (Table II). For the main transcription factor of Th17 cells, RORC, two 
isoforms are described. Two different primer sets were used.  RORC3 primers amplified isoform b; 
RORC4 primers amplified both isoforms a and isoform b (Figure 8). Delta CT (Δct) values are 
depicted. A higher Δct resembles lower mRNA expression. An increase of gene expression levels of 
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RORC (RORC3: isoform b; RORC4: isoforms a+b), IL-17, IL-17F, IL-22 and IL-23R was observed 
upon stimulation (p<0.05, Figure 9 A-B, D-G) while RORA was downregulated (p<0.001, Figure 9 C) 
(Lluis et al. Manuscript submitted). Paired Prentice-Wilcoxon test was used for analyses (Ballenberger 
et al. Manuscript submitted). 
 
 
 
 
Figure 8. Primer design for RORC amplification. 2 transcripts described: “RORC isoform a”, also 
known as RORC1; and “RORC isoform b”, also known as RORC2. The primers named RORC3, in 
red, amplify for RORC isoform b; and the primers pair RORC4, in blue, amplifies both RORC 
isoforms a and b. 
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Figure 9. Gene expression of Th17-lineage related markers in CBMCs. Δct are shown; axes vice 
versa; lower Δct values between groups correspond to increased mRNA expression. Data are shown as 
median (interquartile range, IQR). Paired Prentice-Wilcoxon test. U, unstimulated; PHA, 
phytohemagglutinin; LpA, Lipid A; Ppg, peptidoglycan. N=67. *p<0.001. 
 
 
3.2.1.2 Th17 cells were positively correlated with gene expression of regulatory T cell 
markers in cord blood 
To study putative reciprocal differentiation of Th17 and Treg cells in cord blood, a correlation 
between these two cell populations under different stimulation conditions was assessed. Hence, gene 
expression of Th17 makers RORC with respective isoforms, RORA, IL-23R, IL-17, IL-17F, IL-22 and 
Treg markers FOXP3, LAG3 and GITR was analyzed. Gene expression of Th17 transcription factors 
RORC (primers RORC4: isoform a+b,) and RORA were highly positively correlated with FOXP3 
mRNA levels following all conditions under study (PHA; LpA; Ppg; Table IX). The expression of 
3. RESULTS 
 
- 59 - 
isoform b of RORC (primers RORC3) was strongly positively correlated with levels of FOXP3 upon 
PHA stimulation (Table IX). In contrast, IL-17, IL-17F and IL-22 cytokines were positively correlated 
upon innate stimulation (LpA and Ppg) (Table IX). No correlations were found in unstimulated 
conditions (data not shown). Similarly, significant positive correlations between Th17 mRNA markers 
and other Treg-related markers such as LAG3 and GITR were observed (data not shown) (Lluis et al. 
Manuscript submitted). 
Table IX. Correlation between FOXP3 mRNA (Treg cells) and Th17-lineage genes mRNA 
expression. Spearman correlation coefficient test. 
 
PHA, phytohemagglutinin; LpA, Lipid A; Ppg, peptidoglycan. 
RORC3: RORC isoform b; RORC4: RORC isoform a+b 
p= p-value. P values in bold letters reached significance with p≤0.05. 
# 
Spearman’s correlation coefficient r. 
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3.2.1.3 Th17 mRNA markers in cord blood were independent of maternal farm exposure  
Th17 cells were increased in patients with ADs compared to healthy donors (Toda et al. 2003; Bullens 
et al. 2006; Ciprandi et al. 2009; Cosmi et al. 2011). Nevertheless, little is known about Th17 cells in 
early life in a protective environment for development of ADs such as farming exposure. Thus, gene 
expression of Th17 markers was studied in cord blood from a farming population in comparison to a 
reference group. 
IL-23R mRNA expression was significantly lower in unstimulated samples from cord blood of 
farming compared to non-farming mothers (Table X, p=0.02). No other significant differences in gene 
expression of Th17-lineage markers were found between the two groups (Table X) (Lluis et al. 
Manuscript submitted). 
Since Th17 and Treg mRNA markers were correlated in cord blood (Table IX), the data was adjusted 
for FOXP3 mRNA expression. An interaction effect was observed between Treg (FOXP3 mRNA) and 
farming on the Th17 related markers IL-22 (p=0.038) and IL-23R (p=0.052) upon LpA stimulation. No 
significant differences on Th17 markers depending on farming status were observed (data not shown) 
(Lluis et al. Manuscript submitted). 
Neonatal CBMCs from farm exposed mothers (including farming mothers and mothers exposed to 
stable, barn, farm animals and/or farm milk consumption) compared to non-farm exposed mothers 
showed similar effects (data not shown) (Lluis et al. Manuscript submitted). 
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Table X. Gene expression of Th17 markers in CBMCs from neonates from farming mothers 
compared to non-farming mothers. A positive estimate resembles lower gene expression. Tobit 
regression on rank transformed data is depicted. N=67. 
 
 
U, unstimulated; PHA, phytohemagglutinin; LpA, Lipid A; Ppg, peptidoglycan. 
RORC3: RORC isoform b; RORC4: RORC isoform a+b 
p= p-value. P values in bold letters reached significance with p≤0.05. 
 
3.2.1.4 Maternal farm exposure influenced the Th17 and regulatory T cell correlation 
A significant interaction effect was found in CBMCs between Treg cells and maternal farming status 
on Th17 markers. Consequently, the correlation between gene expression of FOXP3 (Treg cells) and 
Th17-lineage genes was determined in CBMCs stratified by maternal farming status in order to assess 
whether the Th17/Treg correlation was different in these two groups (Table XI).  
A positive correlation was observed upon stimulation (PHA; LpA; Ppg) within CBMCs of non-
farming children (Table XI). In the farming group, gene expression of Th17 and Treg markers was 
positively correlated upon PHA and Ppg stimulation, but not in LpA-stimulated samples (Table XI) 
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(Lluis et al. Manuscript submitted). The data indicate a stimulus-specific effect on Th17/Treg 
regulation in neonates with low maternal exposure to LpA, the main active component of endotoxin, 
compared to neonates with maternal farm exposure, where no effect was observed in CMBCs. 
 
Table XI. Correlation between FOXP3 mRNA (Treg cells) and Th17-lineage genes mRNA 
expression in CBMCs stratified by maternal farming status. Spearman correlation coefficient. 
  
 
U, unstimulated; PHA, phytohemagglutinin;  
LpA, Lipid A; Ppg, peptidoglycan. 
RORC3: RORC isoform b; RORC4: RORC 
isoform a+b 
p=p-value. P values in bold letters reached 
significance with p≤0.05. 
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3.2.1.5 Effect of retinoic acid on mRNA expression of Th17 and regulatory T cells 
Retinoic acid (RA), a derivate of vitamin A, is a key regulator of the Th17/Treg cell regulation 
(Mucida et al. 2007; Bai et al. 2009). As data suggest an interaction between Th17 and Treg cells in 
cord blood, a potential hypothesis was that RA may already influence Th17/Treg regulation early in 
life. Hence, the effect of different doses of RA in vitro on unstimulated or PHA stimulated CBMCs of 
healthy controls was analyzed and its influence on gene expression of both cell populations was 
measured.   
CBMCs were stimulated with or without PHA and different doses of RA for 48h. Increasing doses of 
RA led to downregulation of Treg and Th17 mRNA markers (Figure 10). RORC (primers RORC4: 
isoform a+b,) was downregulated upon PHA stimulation with 50nM and 100nM RA, while IL-23R 
was downregulated under both conditions, unstimulated and after PHA stimulation with all doses of 
RA (Figure 10, p≤0.05). In addition, lower levels of FOXP3 were detectable in both unstimulated and 
PHA stimulated cells with 50nM and 100 nM retinoic acid (Figure 10, p<0.05) (Lluis et al. 
Manuscript submitted). 
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Figure 10. Effect of retinoic acid on Th17 and Treg cells in CBMCs. Δct are shown; axes vice versa; 
lower Δct values between groups correspond to increased mRNA expression. Data are shown as 
median (interquartile range, IQR). Paired Prentice-Wilcoxon test. U, unstimulated; PHA, 
phytohemagglutinin, N=7. 
 
In summary, Th17 cells were present in cord blood at low levels. Maternal farm exposure did not 
influence gene expression of Th17-lineage markers at birth. Furthermore, cord blood Th17 and Treg 
cells were positively correlated upon stimulation (PHA; Ppg) in both farming and non-farming 
children. Upon LpA stimulation, only the non-farming group showed positive correlation between 
Th17 and Treg cells, suggesting an influence of maternal farming at this early stage of immune 
maturation. 
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3.3 The role of genetic polymorphisms on T cells and other markers 
at birth 
In addition to environmental factors, genetic polymorphisms are known to influence the immune 
system with a subsequent effect on the risk of developing ADs (Cameron et al. 2006; Schedel et al. 
2008; Schedel et al. 2009).   
In the present study, genetic variants located within genes of the Th17 pathway, a T cell subset that 
play a role in the pathogenesis of ADs  (Toda et al. 2003; Bullens et al. 2006; Ciprandi et al. 2009; 
Cosmi et al. 2011), were examined in cord blood. The aim was to assess whether these polymorphisms 
may already influence Th17 and other T cell subsets including Treg, Th1 and Th2 cells at this early 
stage of immune maturation (Lluis et al. Manuscript submitted).  
In addition it was analyzed if genetic variants within the chromosomal region 17q2,1 previously 
associated with childhood asthma (Moffatt et al. 2007; Moffatt et al. 2010) influencing ORMDL3 and 
GSDMB gene expression (Moffatt et al. 2007; Verlaan et al. 2009; Halapi et al. 2010), may already 
influence the immune system in cord blood. Thus, genetic variants within 17q21 region were 
examined in relation to the expression levels of Th17, Treg, Th1 and Th2 cell markers at birth. In a 
subsample, it was investigated if 17q21 polymorphic alleles influenced expression levels of the genes 
located within the 17q21 region (ORMDL3, GSDMA, GSDMB, ZNFN1A3, ZPBP2 and PSMD3) in 
cord blood (Lluis et al. 2011).    
 
3.3.1.1 The role of polymorphisms within genes of the Th17-lineage in cord blood 
The impact of polymorphisms within Th17-lineage genes on mRNA expression of Th17- and Treg- 
related genes and protein cytokine secretion was studied in cord blood (the PAULCHEN study).  
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3.3.1.1.1 SNP characteristics 
Seven SNPs located within the IL-17, IL23R and RORC genes and previously known to be relevant for 
childhood asthma (Michael Kabesch, personal communication) were genotyped (Table XII). The 
genotyping success rate was at least 96%. None of the polymorphisms significantly deviated from 
Hardy-Weinberg equilibrium. 
 Analyses were performed using the recessive and dominant model. The best fitting model was applied 
to avoid heterozygous effects observed in the linear model and to receive enough statistical power 
(Lluis et al. Manuscript submitted).   
 
 
Table XII. Description of analyzed SNPs in the Th17 pathway genes and their respective rs number, 
position in the gene structure and allele frequency. 
 
* Based on the genes sequences obtained from Ensembl (http://www.ensembl.org; NCBI36 Release 54, 
May2009) 
# CEU: Utah residents with Northern and Western European ancestry from the CEPH collection. Data obtained 
from SNPPER database (http://snpper.chip.org/) 
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3.3.1.1.2 Polymorphisms within the Th17-lineage genes influenced T cell subsets and other immune-
related markers in cord blood 
In a recessive model, homozygous carriers of the polymorphic allele of rs7517847 (IL-23R) showed a 
significant downregulation of Th17-lineage markers for IL-23R (LpA, Ppg), IL-17 (LpA), IL-17F (U, 
LpA, Ppg) and IL-22 (LpA) mRNA expression; and of IL-17 (LpA, Ppg) protein secretion (p≤0.04) 
(Table XIII, A-Table I in Appendix). A similar trend was observed for homozygous carriers of the 
polymorphic allele of rs2275913 located in the IL-17 gene. In homozygous carriers of the polymorphic 
allele of rs790631 (IL23R) an upregulation of Th17-lineage markers RORC (isoform b; Ppg) and IL-
17F (U) gene expression was detectable. In contrast, lower expression levels of IL23R (PHA) and 
FOXP3 (Ppg) mRNA levels (p≤0.05) (Table XIII, A-Table I in Appendix) were observed in the 
presence of the polymorphic allele of rs790631 (Lluis et al. Manuscript submitted).  
As rs10889675 in IL-23R has a minor allele frequency (MAF) of 0.14 (Table XII) only one subject in 
the PAULCHEN study population was found to be homozygous for the polymorphic allele. Thus, the 
dominant model was applied for rs10889675. A downregulation of Th17-lineage markers (U: RORC 
isoform b, RORA, IL-22) and increased gene expression levels for FOXP3 (LpA) were observed 
(Table XIII, A-Table I in Appendix). In carriers of the polymorphic allele of rs10889675 
downregulation of the respective cytokines IL-5 (PHA, Ppg), IL-13 (PHA), IL-6 (PHA), and IL-15 
(PHA, LpA) (p≤0.05) was present after stimulation (Table XIII, A-Table I in Appendix).  
None of the other SNPs under study significantly influenced gene or protein expression levels of Treg 
and Th17 markers (data not shown) (Lluis et al. Manuscript submitted). 
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3.3.1.2 The role of asthma-associated polymorphisms within the 17q21 region in cord blood 
It has previously been demonstrated that genetic variants in a determined pathway may influence the 
expression of other cell subsets not directly related to the pathway (Liu et al. 2011; Casaca et al. 
2012). Indeed, in this study, polymorphisms within the Th17-lineage genes influenced gene expression 
of FOXP3, the main transcription factor of Treg cells, in cord blood. 
In two Genome Wide Association Studies (GWAS), genetic variants of the 17q21 locus were strongly 
associated with childhood asthma (Moffatt et al. 2007; Moffatt et al. 2010) and influenced 
transcription levels of ORMDL3 and GSDMB (Moffatt et al. 2007; Verlaan et al. 2009). However, 
little is known about the role of 17q21 polymorphisms in an early stage of immune maturation.  
For this purpose, 200 neonates including the PAULINA and the PAULCHEN datasets were recruited. 
Gene expression and cytokine secretion of T cell subsets and mRNA expression of genes located 
within 17q21 region were assessed before and following microbial (LpA; Ppg); PHA or Derp1  
stimulation and related to genetic variants within the 17q21 locus (Lluis et al. 2011).  
 
 
3.3.1.2.1 SNP characteristics 
Genotyping of 10 SNPs within the 17q21 locus previously shown to be relevant for childhood asthma 
was performed (Moffatt et al. 2007) (Figure 11; Table XIV). The genotyping success rate was at least 
94%, whereas rs2290400 (block 1) was excluded from all analyses because genotyping was not 
successful. None of the polymorphisms significantly deviated from Hardy-Weinberg equilibrium 
(HWE) (Table XIV). As allele frequencies for most of the 17q21 SNPs were close to 50%, the 
respective risk allele (instead of the minor allele) was reported (Table XIV). The respective risk allele 
was defined as the allele increasing the risk for development of childhood asthma corresponding to  
GWAS (Moffatt et al. 2007). 
Linkage disequilibrium (LD) analyses identified 4 major LD blocks (Figure 11), each represented by a 
tagging SNP (rs7216389, rs4795405, rs8079416, rs3859192) (Lluis et al. 2011). 
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Figure 11. Genomic structure, localization, and linkage disequilibrium (R
2
 plot) of the genotyped 
polymorphisms in the 17q21 locus. Arrows indicate transcriptional direction. Exons with exon 
numbers are displayed in color codes. Smaller red boxes represent 5’ and 3’ untranslated regions. 
Tagging SNPs (R
2
>0.85) for each linkage disequilibrium block (brackets) are depicted in boldface. 
Chr, Chromosome; Mb, Megabase. 
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Table XIV. Genotyping information for polymorphisms within the Chr17q21 locus (N=200). 
 
 
AF=allele frequency. p=p-value.
 
Bold letters represent the identified tagging SNPs for the 17q21 locus based on R
2
>0.85. 
 
1
 Because AFs for most of the 17q21 SNPs were close to 50%, the respective risk allele (instead of the minor 
allele) is depicted. This was defined as the allele increasing the risk for the development of asthma as shown in 
previous publications (Moffatt et al. 2007). 
2
 LD=linkage disequilibrium. 
3
, p-value of 
2
 test for deviation of Hardy-Weinberg Equilibrium. 
4 
Genotyping failed for rs2290400. 
 
 
 
 
3.3.1.2.2 The asthma-associated risk diplotypes within the 17q21 region influenced ORMDL3 and 
GSDMA gene expression  
As previously described, polymorphisms within the 17q21 region influenced the gene expression of 
ORMDL3 and GSDMB, two genes located within the locus (Moffatt et al. 2007; Verlaan et al. 2009; 
Halapi et al. 2010). However, little is known about the influence of these polymorphisms on mRNA 
levels of genes located within this region in early life. 
For these analyses, haplotype frequencies were estimated on the basis of the four 17q21 tagging SNPs. 
A haplotype is a set of alleles of polymorphisms that are transmitted together to the next generation. 
Unlike genotype, these polymorphisms are located on a single chromatide and are not detectable on 
both strands of a chromosome. Two haplotypes were observed that contained either only non-risk 
alleles of 17q21 (H1 frequency, 0.36, Table XV) or the combination of the respective risk alleles (H2 
frequency, 0.29; Table XV). Because linkage disequilibrium (LD) is strong in the 17q21 region and 
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risk and non-risk alleles were almost equally distributed, it was possible to select a number of children 
that were either homozygous for the risk alleles at all 4 SNP loci (N=9) and to compare these with 
homozygous carriers of the non-risk alleles (N=8) at the respective positions (diplotypes). 
 
Table XV.  Estimated haplotypes based on the four tagging SNPs within the chromosome 17q21 
region and their frequencies (N=187 with complete phase information). 
 
H1 represents the non-risk and H2 the risk haplotype. 
 
Children homozygous for all 4 risk alleles for 17q21 tagging SNPs showed increased expression for 
ORMDL3 (Derp1) and GSDMA (PHA /Derp1); both remained significant after adjustment for multiple 
testing (*; Figure 12, A and B).  
Furthermore, it was assessed whether the combination of 17q21 risk diplotypes also influenced mRNA 
expression of other genes located within the 17q21 cluster including GSDMB, ZNFN1A3, ZPBP2, and 
PSMD3. When homozygous carriers of the four 17q21 risk alleles and carriers of non-risk alleles were 
compared, a trend to decreased expression of ZNFN1A3 after peptidoglycan stimulation was 
detectable (Figure 12, D). No significant effect on gene expression for the additionally analyzed genes 
of 17q21 (GSDMB, ZPBP2, PSMD3) was observed (Figure 12, C, E, F) (Lluis et al. 2011). 
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The data on ORMDL3 and GSDMA was in accordance with the effects observed for individual risk 
alleles of each tagging SNPs (data not shown). 
 
 
 
 
Figure 12. ORMDL3 and GSDMA gene expression was increased in homozygous carriers of the risk 
haplotype (black bars) in comparison with the non-risk haplotype (white bars) after Derp1 and/or PHA 
stimulation in CBMCs. mRNA expression of genes located in 17q21 locus (N=9/8). ΔCT values are 
shown; axes are vice versa; lower ΔCT values between groups correspond to increased mRNA 
expression. Data are shown as median (interquartile range, IQR), analyzed applying the Wilcoxon test. 
mRNA expression was assessed in homozygous subjects for the risk or the non-risk haplotype. U, 
unstimulated; PHA, phytohemagglutinin; LpA, Lipid A; Ppg, peptidoglycan; Derp1, house dust mite. 
*Significance of p≤0.004 (below the multiple testing significance threshold). 
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3.3.1.2.3 Polymorphisms in the 17q21 cluster influenced IL-17 expression in cord blood 
As previously described, polymorphisms within a specific pathway may affect the transcription and 
protein levels of other genes not directly related to their respective downstream pathways (Liu et al. 
2011; Casaca et al. 2012). Hence, it was hypothesized that polymorphisms in the 17q21 cluster may 
influence T cell cytokine secretion. In this study, none of the presented tagging SNPs influenced Th1 
(IFN-) or Th2 (IL-13, IL-5) cytokine secretion, or Treg cell markers (FOXP3, GITR, LAG3 mRNA 
expression; data not shown). 
However, homozygous carriers of the risk allele of each tagging SNP individually within the 17q21 
locus (rs7216389, rs4795405, rs8079416, rs3859192) showed increased IL-17 secretion in 
unstimulated (U) and PHA (Table XVI) but not innate (LpA, Ppg) stimulated cord blood samples (data 
not shown). When polymorphisms within one LD block were analyzed separately, similar results were 
observed for each SNP (A-Table II, A and B). IL-17 secretion was detectable but low. Both parametric 
and non-parametric tests showed significance for the same associations. To address the question of 
whether polymorphic alleles on the 17q21 locus may have an effect on IL-17 secretion primarily for 
the children with risk for atopy, geometric mean rations (GMRs) were adjusted for maternal atopy. 
Yet no significant influence of maternal atopy on the association of IL-17 and the respective genotype 
was observed in cord blood (Table XVI, A-Table II, A and B) (Lluis et al. 2011). 
In summary, polymorphic alleles within the Th17-lineage genes showed an effect on cord blood T 
cells and cytokine secretion while genetic variants within the asthma-associated region 17q21 
influenced IL-17 secretion and ORMDL3 and GSDMA gene expression already in cord blood. Thus, 
genetic polymorphisms may play an important role on immune maturation and potentially impact the 
development of atopic diseases in childhood. 
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Table XVI. Risk alleles of 17q21 tagging SNPs increased IL-17 secretion in unstimulated and PHA 
stimulated cord blood (max. N=200). 
 
 U, unstimulated; PHA, phytohemagglutinin. p=p-value.  
1
 the respective risk allele was defined as the allele increasing the risk for the development of asthma as shown in 
the original publication (Moffatt et al. 2007). 
2
 GMR = Geometric mean ratio, 95% CI = 95% confidence interval.   
3
 p-value of geometric mean ratio by regression models using an allele-counting model (0, 1, 2) for coding of the 
respective SNP.  
 
 
 
 
 
 
 
 
 
 
4. DISCUSSION 
- 76 - 
4 Discussion 
Early childhood is a time period which plays a key role on immune maturation. During this time frame 
both environmental exposures and genetic predisposition are thought to modulate the immune system, 
influencing the risk of developing atopic diseases (ADs). In this context, children being exposed to 
farming environment revealed a lower prevalence of ADs (von Mutius et al. 2010; Lluis et al. 2012). 
Besides Th1 and Th2 cells, other T cell subsets including regulatory T (Treg) and Th17 cells have 
been identified to be involved in the manifestation of ADs. Nevertheless, little is known about the 
mechanistic contribution of Treg and Th17 cells during immune maturation influenced by 
environmental and genetic factors for the development of ADs in childhood. 
The present data demonstrates that FOXP3 demethylation at the Treg-specific demethylated region 
(TSDR) is a valuable and reliable marker to assess Treg cells in cord blood (Liu et al. 2010).  In 
neonates, it has previously been shown that FOXP3 demethylation at the TSDR was associated with 
maternal farm exposures. In the same study, Treg cells counts were increased in cord blood from 
farming mothers (Schaub et al. 2008). Here is shown that Treg cells (%) were increased in 4.5-year-
old children living in a farm and/or drinking farm milk while they were negatively associated with 
inhalant IgE (Lluis, Depner et al. Manuscript submitted). In contrast, maternal farming did not 
influence Th17 cells in cord blood; yet, in this population Treg and Th17 cells were positively 
correlated upon stimulation, influenced by maternal farming (Lluis et al. Manuscript submitted). In 
addition, the present study indicates an effect of genetic variants within the Th17-lineage genes (Lluis 
et al. Manuscript submitted) and the asthma-associated region 17q21 (Lluis et al. 2011) on gene 
expression and cytokine secretion already in neonates. 
In this study it was demonstrated that FOXP3 demethylation at the TSDR is a suitable and reliable 
marker to assess Treg cells in cord blood. Quantification of Treg cells isolated from cord blood may be 
not feasible, especially in large field studies due to methodological challenges. However, the present 
study indicates that FOXP3 demethylation levels in EDTA-blood directly corresponded to a higher 
suppressive capacity of Treg cells and with standard Treg cell markers such as FOXP3 mRNA 
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expression and CD4
+
CD25
high
 cells in unstimulated and Lipid A (LpA)-stimulated samples (Liu et al. 
2010). Recent studies demonstrated that demethylation of FOXP3 at the TSDR region was a reliable 
marker to quantify Treg cells in adults and mice (Baron et al. 2007; Floess et al. 2007). TSDR, a 
conserved region within the FOXP3 locus, was demethylated in CpG motifs in natural Treg (nTreg) 
but not in CD4
+
CD25
-
 T, in vitro induced FOXP3
+
 Treg cells or transiently activated FOXP3
+
 T cells 
(Baron et al. 2007; Floess et al. 2007). So far, the markers used to define nTreg cells quantitatively 
included FOXP3 expression - the Treg transcription factor (Fontenot et al. 2005); CD4
+
CD25
high
, 
CD4
+
CD25
high
FOXP3
+
 or CD4
+
CD25
high
CD127
low/-
 (Shevach 2006); or functional examination of Treg 
cells through assessment of their suppressive capacity. However, these techniques require large 
amounts of cells and may therefore not always be feasible. 
Some major advantages of determining Treg cells through FOXP3 demethylation compared to other 
Treg parameters is the stability of DNA methylation compared to mRNA expression or protein 
synthesis (Baron et al. 2006). In contrast to other techniques such as suppression assays or flow 
cytometry, methylation analysis can be performed at any time point independent of sample 
withdrawal. Nonetheless, present studies have only been performed in adults (Baron et al. 2007; 
Floess et al. 2007), and the potential of TSDR demethylation as a marker for cord blood Treg cells 
remained unclear. 
In this study it was demonstrated that FOXP3 demethylation at the TSDR was restricted to 
CD4
+
CD25
high
 cells in cord blood, while it was generally very low in CD4
+
CD25
-
 cells. Thus, FOXP3 
demethylation was restricted to Treg cells. Furthermore, FOXP3 demethylation in EDTA-blood 
clearly correlated with CD4
+
CD25
high
 expression but to a lower extent with FOXP3 mRNA expression 
in cord blood mononuclear cells (CBMCs). The latter maybe explained by the fact that the analyses 
were performed in bulk culture and measured FOXP3 gene expression may also encompass its 
expression of non-Treg cells. In addition, FOXP3 demethylation was indicated as a dependable marker 
to determine Treg cell functional capacity in cord blood since it positively correlated with Treg 
suppression activity on divison of effector T cells and trendwise with Treg suppression on 
proliferation of effector T cells. Since TSDR demethylation was assessed in EDTA-blood, the 
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percentage was low; yet, methylation status was analyzed in whole blood, which contains a mixture of 
cell subsets. From those, only Treg cells were demethylated at the TSDR region in FOXP3 locus. The 
data suggest that the methylation status of the TSDR in FOXP3 using whole cord blood is a valid 
method to determine Treg cells instead of studying them in mononuclear cells or isolated Treg cells. In 
conclusion, FOXP3 demethylation is a reliable marker to assess quantitatively and qualitatively Treg 
cells in early life (Liu et al. 2010). 
Interestingly, these effects were observed not only in unstimulated samples but also after stimulation 
with LpA. The TLR4-ligand LpA, part of the endotoxin of the gram-negative bacteria, was used to 
quantify Treg activity using a stimulus which mimics microbial exposure as a “protective stimulus” 
against allergy development. The data on LpA-stimulated samples suggest that FOXP3 demethylation 
is also a valuable marker to assess the activity of Treg cells in children exposed to rich microbial 
burden such as children living on a farm (Liu et al. 2010).  
Growing up on a farm indeed decreases the risk to develop ADs in childhood (Von Ehrenstein et al. 
2000; Riedler et al. 2001; Alfven et al. 2006). Notwithstanding that the underlying mechanisms are 
not clear to date. Immune regulatory mechanisms including upregulation of innate immune receptors 
are suggested to be involved, with the strongest effects upon prenatal farming exposure (Lauener et al. 
2002; Ege et al. 2006). In this context, Treg cells have been shown to be increased and functionally 
more efficient in neonatal cord blood of farming families (Schaub et al. 2009), supporting the 
hypothesis that the “farm effect” starts already in utero. Here it is demonstrated in another birth cohort 
(the PASTURE/EFRAIM Study) that Treg cells were increased in farming compared to reference 
children at age 4.5 years. The data suggest a long-lasting effect of the farming environment on 
increased Treg cells that may influence the development of ADs in childhood. Indeed, Treg as well as 
activated T cells were increased, suggesting that both may be relevant for the protective “farm effect”. 
Only further investigations will provide additional knowledge to understand the functional relevance 
of these findings (Lluis, Depner et al. Manuscript submitted). 
Of note, one need to consider to additionally take into account the best markers to determine Treg 
cells, the identification of the specific type or types of exposure mediating similar or potentially 
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different regulatory mechanisms, the timing and duration of exposure and the effect on clinical atopic 
phenotypes such as atopic sensitization (Lluis, Depner et al. Manuscript submitted).  
Several markers are currently used to determine Treg cell numbers including high expression of the 
IL-2 receptor (CD25), low surface expression of CD127 (Liu et al. 2006), or intracellular expression 
of FOXP3 (Shevach 2006). Nevertheless, the expression of the main transcription factor, FOXP3, is 
still considered the most specific marker to define Treg cells (Fontenot et al. 2005) (Lluis, Depner et 
al. Manuscript submitted).  
When studying the effect of certain farm exposures detailed analysis revealed an influence of farm 
milk consumption on Treg cells upon stimulation (PI=PMA/Ionomycin; LPS= Lipopolysaccharide). 
Several studies reported the relation between farm milk consumption and lower risk of ADs (Braun-
Fahrlander et al. 2011). Although the specific underlying mechanisms are not known, the latter 
findings suggest that it maybe partially explained through altered regulation of Treg cells. In the 
ALEX study, farm milk consumption during the first year of life was associated with a reduced risk to 
suffer from asthma, hay fever or atopic sensitization during school-age (Riedler et al. 2001). In 
contrast, farm milk consumption ever in life in the PARSIFAL study was associated with lower 
prevalence of asthma, rhinoconjunctivitis, sensitization to pollen and food allergens (Waser et al. 
2007). Analyses regarding raw milk consumption in the GABRIELA study showed an inverse 
association with asthma, atopy and hay fever (Loss et al. 2011). Other farm-related exposures 
analyzed such as staying in stables (Riedler et al. 2001; Ege et al. 2006) or contact to hay (Ege et al. 
2007) have been associated with the “farm effect”. However, no correlation with increased Treg cells 
was observed. Based on these findings one may speculate that different mechanisms are involved in 
the protective effect driven by atopy including environmental exposures linked to farming. While Treg 
cells may evoke a protective effect through farm milk consumption, additional or different 
mechanisms seem to be involved after the exposure to other farm-related factors (Lluis, Depner et al. 
Manuscript submitted). 
Further analysis on the different types of milk revealed that both, the consumption of farm milk alone 
or in combination with shop milk, were associated with increased Treg cells at age 4.5 years upon 
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stimulation (PI, LPS). Drinking boiled or unboiled farm milk had similar effects on Treg cells. Farm 
milk and specifically raw milk consumption is one of the most discussed farm exposures in relation to 
the allergy-protective “farm effect” (von Mutius et al. 2010; Braun-Fahrlander et al. 2011). Other 
studies observed a negative association of raw farm milk consumption with asthma, hay fever (Loss et 
al. 2011), eczema (Wickens et al. 2002; Perkin et al. 2006) and atopy (Barnes et al. 2001; Radon et al. 
2004; Perkin et al. 2006; Loss et al. 2011). Raw milk may contain more bacteria, including pathogenic 
strains than boiled milk (Perkin 2007). Milk treatments such as heating and homogenization may 
affect heat-sensitive milk components or the physical structure of fat milk, respectively, and 
subsequently abrogate the farm milk effect on allergy protection (Braun-Fahrlander et al. 2011). 
However, this study did not reveal major differences depending on farm milk boiling status. One may 
therefore speculate that Treg cells are rather modulated by farm heat-resistant milk components 
synergistically through alternative mechanisms involving other farm milk components (Lluis, Depner 
et al. Manuscript submitted).  
Of note, the effect of farm milk consumption on Treg cells in the present study was even stronger 
within the non-farming compared to the farming children which was even more pronounced in 
subjects without any contact to stables. These data suggest a potential “saturation” effect for farming 
children drinking farm milk as farming children are continuously in contact with several other farm-
related exposures possibly affecting Treg cell numbers. In contrast, the reference group drinking farm 
milk has few or even no contact to farming environment, in particular those without any contact to 
stables. In line with this observation Barnes et al. (Barnes et al. 2001) described a lower prevalence of 
atopy among children that consumed unpasteurized milk products early in life. However, when 
stratified analysis were applied, the association was only discernible among the urban children but not 
among the rural children (Barnes et al. 2001) (Lluis, Depner et al. Manuscript submitted). 
The strongest effect of farm milk exposure on Treg cells was consistently observed upon LPS 
stimulation and to a lower extent after PI stimulation while solely some effects were detected in 
unstimulated conditions. PI is a potent polyclonal stimulus that strongly activates proliferation of T 
cells, while LPS, an endotoxin found in the outer membrane of the gram-negative bacteria, is a TLR4 
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ligand present in high amounts in the farming environment (Braun-Fahrlander et al. 2002). The data 
suggest that previous continuous exposure to LPS promote a stronger Treg cell response in childhood. 
Interestingly, among farm milk drinkers’ stronger responses were observed in the non-farming group, 
in particular without any contact to stable. This may lead to the hypothesis of an additive effect 
existing for non-farming children who consume farm milk. The finding is of special relevance as a 
larger percentage of the population is affected by this outcome. Yet, this effect and the underlying 
immunological mechanisms controlled by exposures present in stables need to be further investigated 
(Lluis, Depner et al. Manuscript submitted).  
Regarding time and length of exposure, farm milk consumption during pregnancy and early childhood 
revealed a stronger positive association with Treg cells than farm milk consumption only in childhood. 
Although no effect was observed when exposure occurred only during pregnancy, the data need to be 
interpreted carefully as the subgroup was rather small and the time points are highly correlated. The 
early influence of in utero exposure to farming or farm milk consumption may contribute to the 
neonatal immune system has previously been reported. In the PARSIFAL study, prenatal farm 
exposure was associated with increased levels of pattern recognition receptors in childhood (Ege et al. 
2006) and previous data in the same study population revealed an association between maternal farm 
milk consumption and higher IFN- levels in cord blood (Pfefferle et al. 2010). IFN- presence in cord 
blood has been associated with lower risk of atopic diseases in childhood (Macaubas et al. 2003) 
(Lluis, Depner et al. Manuscript submitted). 
Treg cells were additionally correlated with clinical atopic outcomes including lower inhalant IgE in 
unstimulated conditions, suggesting a protective role for Treg cells on atopic sensitization. Yet, a more 
detailed assessment of atopic sensitization and asthma in relation to Treg cells later in childhood is 
required (Lluis, Depner et al. Manuscript submitted).  
In parallel to the in depth analyses of Treg cells, the aim of this study was to assess the role of Th17 
cells in a farming population early in life. Th17 cells have been shown to be increased in ADs (Tesmer 
et al. 2008). Growing up on a farm was reported as a protective factor for the development of ADs 
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(Riedler et al. 2001; Alfven et al. 2006; Ege et al. 2011), specially when exposures occur already in 
utero. Thus, time of exposure to farming is crucial for this protective effect (Ege et al. 2006). Based on 
these previous findings, it maybe suggested that Th17 cells are downregulated in cord blood from 
farming children. From this study two specific questions were addressed. First, it was investigated 
whether Th17 cells were influenced by maternal farm exposure in cord blood. Second, it was studied 
whether Th17 and Treg cells were reciprocally regulated at birth (Lluis et al. Manuscript submitted).  
Thus, Th17 cells- determined by gene expression of Th17-lineage genes- were already detectable in 
cord blood. Characteristic Th17-lineage genes including the transcription factor RORC, the 
transmembrane receptor IL-23R and several cytokines such as IL-17, IL-17F and IL-22 were increased 
upon specific stimulation. For RORA mRNA expression a slightly downregulated was observed. Of 
note, this study was performed in unfractionated cord blood mononuclear cells. Therefore, the cell 
source of gene expression cannot be specified to a certain sub-cell population. Although Th17-lineage 
markers are characteristic of this cell subset, they are not exclusively expressed in Th17 cells 
(Dzhagalov et al. 2004) (Lluis et al. Manuscript submitted).  
In a next step, the role of maternal farm exposure on cord blood Th17 cells –comprehensively assessed 
by gene expression of Th17-lineage genes- was determined. Maternal farming did not reveal any 
effect on gene expression of Th17 markers in cord blood per se (Lluis et al. Manuscript submitted). 
These data are consistent with previous results on IL-17 protein secretion in the same birth cohort, 
where no differences were observed between farming and non-farming CBMCs (Schaub et al. 2009) 
(Lluis et al. Manuscript submitted).  
One of the main findings of this study demonstrated that gene expression of Th17-lineage markers was 
positively correlated with Treg cells upon stimulation. Several studies reported a close relationship 
between these two subsets. For instance, Treg cells are known to limit the immunopathology of  Th17-
driven diseases such as inflammatory bowel disease (IBD) (Sakaguchi et al. 2007). A higher ratio of 
Th17/Treg cells has been related to graft versus host disease (Ratajczak et al. 2010). Later studies in a 
mouse model demonstrated that FOXP3
+
 Treg cells are required for development of Th17 cells in vivo 
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in a IL-2 dependent manner (Chen et al. 2011) (Lluis et al. Manuscript submitted). Interestingly, the 
positive correlation upon stimulation was not observed within the farming group after LpA 
stimualtion. LpA is the main active component of endotoxin, abundant in the farming environment. 
The data suggest a stimulus-specific effect between these two subsets in neonates with low exposures 
to endotoxin (non-farming group), or no effect in previously exposed neonates (farming group). This 
is consistent with the interaction effect observed between Treg cells and farming on Th17-lineage 
genes upon LpA stimulation (Lluis et al. Manuscript submitted). 
The positive correlation between Th17 and Treg cells in cord blood points out a parallel regulation of 
both subsets at this early stage of immune maturation. In concordance, Chen et al. recently described 
in a murine model that Treg and Th17 cells were positively regulated in early stages of immune 
development through IL-2. While Treg cells required IL-2 for their expansion, Th17 development was 
inhibited by IL-2. However, the effect was only present in early stages of Th17 development. 
Putatively, the parallel regulation only occurs in the first phases of differentiation and Treg cells may 
inhibit Th17 cell responses in a later phase of inflammation (Chen et al. 2011). Thus, the positive 
correlations observed in the PAULCHEN population in cord blood may be different later in childhood 
(Lluis et al. Manuscript submitted). On this account, Th17 and Treg cells demonstrate certain 
plasticity (Voo et al. 2009) and several factors may contribute to their lineage fate including external 
factors like the cytokine milieu (Kimura et al. 2010) or the presence of regulatory metabolites (Mucida 
et al. 2007). In addition, genetic regulation may also play a role on the fate of both cell subsets, e.g. 
through direct or indirect interaction of FOXP3 and RORC transcription factors that may regulate the 
cell fate (Ichiyama et al. 2008; Zhang et al. 2008) (Lluis et al. Manuscript submitted).  
Indeed, an important regulatory metabolite of Th17/Treg regulation is retinoic acid (RA), a derivate of 
vitamin A. Hence, the influence of Th17/Treg cell fate upon RA stimulation early in life was assessed 
in this study. RA-treated cord blood samples showed a downregulation of Th17 (RORC, IL-23R) and 
Treg (FOXP3) markers. A dose-response effect, especially upon PHA stimulation was observed. RA is 
relevant for immune cell differentiation and maintenance of immune homeostasis (Bai et al. 2009) and 
can enhance iTreg (induced Treg cells) cells (Mucida et al. 2007; Nolting et al. 2009) while 
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suppressing Th17 differentiation in mice (Mucida et al. 2007). One may speculate that RA regulates 
both populations in opposite directions during an inflammatory process. In cord blood, the parallel 
regulation of both Th17 and Treg cells upon RA treatment is in line with the overall regulation 
detectable in the study. The findings may be related to a dose-dependent response to RA, although the 
doses used were comparable to other studies; or the results may reflect a specific strong parallel 
regulation of Th17 and Treg cells at birth. Further investigations are required, including functional 
characterization of the cell subsets. This specific question was not addressed in this study due to too 
low cell numbers and logistic issues (Lluis et al. Manuscript submitted).  
Overall, a parallel regulation of both Th17 and Treg cells was observed at birth upon different 
stimulation conditions. While exposure to RA downregulated T cell markers of both populations, PHA 
and Ppg stimulation increased the expression of both Th17- and Treg- lineage markers independent of 
maternal farm exposures. Upon LpA stimulation, a positive Th17/Treg correlation was only observed 
within the non-farming group, but not in farming children. Differences between both groups suggest a 
potential role of prenatal farm exposure on the interaction between these two T cell subsets. A follow-
up of the cohort, including a functional characterization of the T cell populations, is required to 
enlighten whether these findings might influence the development of ADs later in childhood.  
In addition to environmental factors influencing Th17 and Treg cells, genetic relevance of 
polymorphisms within the Th17-lineage pathway and the asthma-associated 17q21 region on mRNA 
expression of the related genes and on T cell markers were also examined. Genetic polymorphisms are 
important modulators of the immune system with potential consequences on the susceptibility for ADs 
(Schedel et al. 2008; Suttner et al. 2009).  
Polymorphisms within the Th17-lineage pathway influenced Th17 and other T cells – 
comprehensively assessed by cytokine secretion and gene expression of related markers- already at 
birth. The influence of the polymorphism in the IL-23R rs7517847 on Th17 cell marker expression is 
consistent with findings from a genome-wide association study (GWAS) where this genetic variant 
was a protective factor for IBD, potentially a Th17 driven disease (Duerr et al. 2006). In contrast to 
our results, in a Chinese study of school-age children the polymorphism rs2275913 did not show any 
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difference in IL-17 secretion. However, rs2275913 was associated with childhood asthma and within 
the asthmatic group the SNP was associated with abnormal lung function and higher total IgE in serum 
(Chen et al. 2010). Out of the seven investigated polymorphisms two genetic variants (rs790631, 
rs10889675) revealed an opposite regulation of Th17 and Treg cells. Homozygous carriers of the 
polymorphic allele of rs790631 showed an increase of Th17 markers but a decrease in FOXP3 
expression. Inversely, homozygous carriers of the polymorphic allele of rs10889675 showed higher 
FOXP3 mRNA but lower Th17 and Th2 expression. Of note, since only one child was homozygous 
carrier for this SNP, a dominant model was used. As this was an explorative study, no adjustment for 
multiple testing was applied; instead further study replications are required (Lluis et al. Manuscript 
submitted).    
Hence, SNPs within Th17-lineage pathway affected T cell gene expression already in cord blood. 
Whether this may have an impact later in childhood for the development of atopic diseases requires a 
follow up of the cohort. 
As observed for polymorphisms within the IL-17 and IL-23R genes, the influence of genetic variants 
on gene expression of respective pathway gene is already detectable in early stages of immune 
maturation, with potential influences later in childhood. As little is known about the influence of 
genetic variants of the highly asthma-associated 17q21 locus (Moffatt et al. 2007; Moffatt et al. 2010) 
early in life, the effect of these SNPs in cord blood was investigated.  
Previous studies showed an association between SNPs within 17q21 region with ORMDL3 (Dixon et 
al. 2007; Verlaan et al. 2009; Halapi et al. 2010), GSDMB (Dixon et al. 2007; Verlaan et al. 2009; 
Verlaan et al. 2009; Halapi et al. 2010) and ZPBP2 gene expression (Verlaan et al. 2009) potentially 
due to allele-specific chromatin remodeling within the 17q12-q21 region (Verlaan et al. 2009). In the 
present data not only the previously analyzed candidate genes (IKZF3, ZPBP2, GSDMB and 
ORMDL3) (Verlaan et al. 2009) were analyzed but also GSDMA and PSMD3, additionally located 
within this asthma-associated locus (Lluis et al. 2011). Besides of the previously described increase in 
ORMDL3 expression (Verlaan et al. 2009), higher levels of GSDMA within the risk alleles carriers 
was observed in cord blood. Previous findings on GSDMB and ZPBP2 (Verlaan et al. 2009; Halapi et 
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al. 2010) could not be reproduced in our study population. Differences between studies might be due 
to different cell populations or to the different status of cell immune maturation, since in this study 
gene expression was analyzed in cord blood (Lluis et al. 2011). 
The function of these genes is not fully understood yet. GSDMA was described to induce apoptosis in 
the gastric epithelium and has been suggested as a tumor suppressor (Saeki et al. 2009) while 
Orosomucoid family proteins are involved in the metabolism of sphingolipids in Saccharomyces 
cerevisiae (Breslow et al. 2010). Furthermore, ORMDL3 seems to play a role in Ca
2+
 homeostasis and 
unfolded protein response  (Lewis 2001; Gallo et al. 2006; Cantero-Recasens et al. 2010), which itself 
is involved in downstream events such as effector T cell regulation (Lewis 2001; Gallo et al. 2006; 
Lluis et al. 2011).  
In addition to altered ORMDL3 and GSDMA mRNA expression, an increase in IL-17 secretion was 
observed in carriers of the asthma risk alleles within the 17q21 locus in unstimulated and PHA-
stimulated samples. In parallel, increased levels of IL-17, the main secreted cytokine by Th17 cells, 
have been associated with asthma (Molet et al. 2001; Wong et al. 2001; Barczyk et al. 2003; Bullens 
et al. 2006), atopic eczema (Toda et al. 2003; Koga et al. 2008) and allergic rhinitis (Ciprandi et al. 
2008; Ciprandi et al. 2009). Thus, one may hypothesize that the risk alleles of 17q21 may induce a 
Th17 polarized response early in life that may prone to develop asthma later in childhood. This may be 
in concert with other mechanisms including ORMDL3 and GSDMA/GSDMB expression, as they were 
also influenced by these polymorphic risk alleles. A follow up of this or other studies is very important 
to elucidate the role of these findings and to analyze their contribution on the development of 
childhood asthma (Lluis et al. 2011). 
In conclusion, Treg and Th17 cells are influenced by environmental as well as genetic factors early in 
life with a potential contribution to the development of atopic diseases later in childhood. The 
influence on Treg cells observed in young farming children is of particular interest as farming is 
associated with an allergy-protective effect. Interestingly, farm milk consumption was the most 
relevant farm-related exposure influencing Treg cells, particularly in children not exposed to farming 
environment. Presented data lead to the hypothesis that components in farm milk may contribute to the 
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modulation of the immune system driving a non-allergic phenotype partially mediated through Treg 
cells. Identifying these components is of high interest for the general population since the protective 
effect could then be directly translated.  
In parallel, the close relationship between Treg and Th17 cells at birth is particularly intriguing as their 
gene expression markers were similarly correlated. However, further studies are needed at later phases 
of immune maturation to gain a broader understanding of the reciprocal regulation of both subsets and 
their influence on their cell fate. In addition, both subsets were affected by genetic predisposition 
already early in life. In general, Th17 cells have been shown to be increased in atopic diseases. Based 
on the data presented here, one may speculate that asthma-risk alleles may lead to a Th17 driven 
immune response early in life which may subsequently prone to developing atopic diseases. 
Indisputably, other mechanisms may contribute to the development of atopic diseases in concert with 
Treg and Th17 cells. Comprehensive functional analyses are therefore required to further characterize 
their unique contribution to the pathogenesis of atopic diseases during immune maturation in 
childhood.   
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5 Summary 
Early childhood is a biological window where the immune maturation is thought to be modulated by 
environmental and genetic factors, subsequently influencing the development of atopic diseases 
(ADs). Within the past decade it was clearly shown that not only Th1 and Th2 cells are involved in its 
manifestation but also Treg and Th17 cell subsets play a crucial role. In AD patients Th17 cells were 
indicated to be increased whereas data on Treg cells is rather contradictory.  Yet, little is known about 
the role of these T cell subsets in the development of ADs during immune maturation. In this context, 
growing up on a farm is a protective factor for the development of ADs in childhood. Increased 
numbers and more efficient Treg cells were observed in cord blood from farming compared to non-
farming mothers. 
The present work indicates that the demethylation of FOXP3 gene– the transcription factor of Treg 
cells – at the Treg-specific demethylated region (TSDR) can be used as a reliable marker to assess the 
number and functional activity of Treg cells in cord blood. FOXP3 demethylation has also previously 
been shown to be associated with maternal farming exposures in cord blood. In the present study, 
children at the age 4.5 years exposed to farming environment and/or farm milk consumption revealed 
an increase in Treg cell numbers. In contrast, inhalant IgE was associated with lower Treg cell 
numbers. A positive correlation between Th17 and Treg cell numbers upon stimulation was influenced 
by maternal farming in cord blood. However, maternal farm exposure did not alter Th17-lineage gene 
expression per se.  
In addition to environmental factors, genetic polymorphisms within the Th17-lineage pathway 
influenced T cell expression in cord blood. The secretion of IL-17 – the major cytokine of Th17 cells – 
was elevated in cord blood samples carrying certain genetic variants of the asthma-associated 17q21 
region. These polymorphisms also influenced the gene expression of two genes (ORMDL3 and 
GSDMA) located within the 17q21 susceptibility locus selective for childhood asthma. 
These data contribute to a better understanding of Treg and Th17 cell regulation during immune 
maturation influenced by environmental as well as genetic factors. Hence, new insights into the 
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potential mechanisms regulating the development of ADs in childhood are provided. A follow up of 
these birth cohorts is currently conducted to assess the correlation of the observed effects on the 
development of AD later in life.   
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DNA   Deoxyribonucleic acid 
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EDTA   Ethylenediaminetetraacetic acid 
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FCS   Fetal Calve Serum 
FOXP3   Forkhead box P3 
FW   Forward 
GABRIELA  GABRIEL Advanced Surveys Study 
GITR   Glucocorticoid-induced TNF receptor 
GMC-SF  Granulocyte-macrophage colony-stimulating factor 
GMR   Geometric mean ratio 
GSDMA  Gasdermin A, alias GSDM1 
GSDMB  Gasdermin B, alias GSDML 
GWAS   Genome-wide association study 
H   Haplotype 
HWE   Hardy-Weinberg equilibrium 
IFN-   Interferon gamma 
IgE    Immunglobulin E 
IL   Interleukin 
IL-23R   Interleukin-23 receptor 
IQR   Interquartile Range 
ISAAC   International Study of Asthma and Allergies in Children 
LAG3    Lymphocyte activation gene-3 
LD   Linkage disequilibrium 
LpA   Lipid A 
LPS   Lipopolysaccharide 
MAF   Minor Allele Frequency 
MALDI-TOF MS Matrix Assisted Laser Desorption-Time of Flight Mass Spectrometry 
mRNA   Messenger RNA  
OR   Odds Ratio 
ORMDL3  Orosomucoid 1–like 3 
p   P-value 
PI   PMA/Ionomycin 
PAULCHEN  Prospective Cord Blood Study in Rural Southern Germany 
PAULINA  Paediatric Alliance for Unselected Longitudinal Investigation of Neonates for 
Allergies 
PASTURE/EFRAIM Protection against allergy: Study of Rural Environments 
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PARSIFAL Prevention of Allergy-Risk factors for Sensitization In children related to Farming and 
Anthroposophic Lifestyle 
PBMC Peripheral blood monocytes 
PBS   Phosphate Buffered Saline 
PCR   Polymerase Chain Reaction 
PHA   Phytohemagglutinin 
PMA   Phorbol 12-myristate 13-acetate 
Ppg   Peptidoglycan 
PRR   Pattern recognition receptors 
PSMD3   Proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 
r   Correlation coefficient 
Real-time RT-PCR Real-time Reverse-Transcriptase-PCR 
RE   Reverse 
RAST   Radioallergosorbent test 
RNA   Ribonucleic acid 
RORA   Retinoic acid receptor-related orphan receptor alpha  
RORC   Retinoic acid receptor-related orphan receptor C 
rs   Reference SNP 
SEM   Standard error of the mean 
SD   Standard deviation 
SNP   Single nucleotide polymorphism 
STAT   Signal transducer and activator of transcription 
TCR   T cell receptor 
Teff   Effector T cell 
TF   Transcription Factor 
Th cell   T helper cell 
TLR   Toll-like receptor 
TNF   Tumor necrosis factor alpha 
Treg   Regulatory T cell 
TSDR    Treg Specific Demethylated Region 
t-test   Statistical test: Student’s t distribution  
U   Unstimulated 
USA    United States of America 
UTR   Untranslated region 
WT   Wildtype allele 
ZNFN1A3  Ikaros family zinc finger 3, alias IKZF3 
ZPBP2   Zona pellucida binding protein 2 
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A-Table I. SNPs within the Th17-lineage genes in relation to Th17 and Treg mRNA markers and 
protein secretion of immune factors including T cell cytokines. General Wilcoxon test. 
 
A. Recessive model 
 
IL23R RS7517847 SNP: G  
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IL23R RS790631 SNP: C  
 
 
 IL17 RS2275913  SNP: A  
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B. Dominant model 
 
IL23R RS10889675 SNP: A 
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U, unstimulated; PHA, phytohemagglutinin; LpA, Lipid A; Ppg, peptidoglycan.  
RORC, primers RORC3: RORC isoform b. 
p=p-value. Data in boldface are significant. 
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A-Table II. Risk alleles of 17q21 SNPs increased IL-17 secretion in unstimulated and PHA stimulated 
cord blood (N=200). 
 
A. Block 1 
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B. Block 3 
 U, unstimulated, PHA, PHA stimulated. p=p-value. 
1
 the respective risk allele was defined as the allele increasing the risk for the development of asthma as shown in 
previous publications (Moffatt et al. 2007). 
2
 GMR = Geometric mean ratio, 95% CI = 95% Confidence Interval.   
3
 p-value of geometric mean ratio by regression models using an Allele-counting model (0,1,2) for coding of the 
respective SNP.  
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